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INTRODUCTION

“Divinity is the special quality that makes us unique — our presence, our love, our creative
energy, are the ways in which we transform our environment.”—Byllye Avery, Founder of the
National Black Women’s Health Project

My professional journey inspired my interest in the GARDASIL® women-focused marketing as an
academic research project. This journey began as an undergraduate student at Spelman College, where I
learned about women‘s rights as a poignant topic. Immediately following the completion of my
undergraduate degree in 2002, I moved to Washington, DC, and began an exciting career in the
reproductive rights movement. I had the opportunity to work with intellectually rigorous, communitycentered and action-oriented young and seasoned feminists at national non-profit organizations, such as
Choice USA, National Center for Human Rights Education, and SisterSong, which shared an unwavering
commitment to developing young women of color‘s leadership, and were a phenomenal place to grow as a
women‘s health advocate. My position was as an organizer and program coordinator. I traveled
extensively both nationally and internationally speaking at major conferences, special events, and press
conferences discussing the critical issues facing young women of color within the reproductive rights
movement. I also organized a Southeast regional student leadership conference that focused on lobbying,
voter education and registration training in order to support young people‘s ability to confidently
participate in the political process.
Due to my career accomplishments, in the Fall of 2003, I was approached by my former executive
director to support organizing efforts for the 2004 ―March for Women‘s Lives‖ in Washington, DC. Upon
acceptance, I began a rigorous, six month, cross-coast travel schedule outreaching to communities of color,
especially women of color, to join the march. Through engaging in this national organizing effort, I
became immersed in the complex politics of the mainstream pro-choice movement. Initially women of
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color were expressing concern about the lack of women of color representation on the national level of
organizing and planning. This was a major turning point in my career. As a woman of color, I found
myself navigating between my role as a representative of the national march organizing team, while
listening and supporting the demands of the women of color not being represented. Pressing on, I
encouraged women of color to bring their unique perspectives about the issue of reproductive choice to the
event. We were able to reach an amenable agreement that included adding well-respected women of color
health advocate organizations to join the leadership table, including: Black Women‘s Health Imperative
and National Latina Institute for Reproductive Health. Our joint efforts reaped a successful result.
Finally, the day arrived, April 25, 2004, and I was on the National Mall by seven o‘clock in the
morning with the other March staff preparing for crowds to arrive en masse by noon. Nearly one million
people stood in solidarity on the national mall for women‘s reproductive freedom and the energy was
inspiring. It was an all-consuming experience that I am very grateful to have the opportunity to have been
apart of. Many outlets weighed in on the numbers of participants and the success of the March. The
Guttmacher Institute stated, ―…hundreds of thousands of men, women, and children gathered in
Washington, DC, to combat efforts to dismantle hard-fought gains in sexual and reproductive health and
rights...taking place in the capital of a global superpower but focused on the needs of disempowered
groups‖(Guttmacher Institute, 2005). My work with the march was a triumphant milestone that both
challenged and matured my understanding of the circuitouspolitics that, at times, consume the reproductive
rights movement.
While working on the march organizing, I had also been elected to the board of directors of a major
women‘s health advocacy organization—the National Women‘s Health Network, or Network
(www.nwhr.org). For more than thirty-five years, the Network has served as a chief and trusted voice
grounded in feminism and ethical science located at in Washington, D.C. The Network works on a broad-
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range of women's health issues, including: ending the medicalization of menopause; the right to universal
health care; and reproductive and sexual health rights. Additionally, we are strategically a membershipbasedorganization relying onour members to give us important feedback on our work and the issues that
are important to them. For ourmembers we offer three important services: monitor/watchdogThe US Food
and Drug Administration or FDA and pharmaceutical industry regarding drugs and medical technologies
that affect women; write critically about women's health and government policies that affect women‘s
health in our quarterly newsletter; and maintain a clearinghouse of information on a variety of women's
health issues. The Network accomplishes these tasks without compromise to our core values of offering an
independent and critical voice on women‘s health in part because we proudly refuse direct funding
fromtobacco, alcohol, pharmaceutical, and petroleum companies. Moreover as a Network leader, I am
required to have a broad knowledge of women‘s health issues; hence, I began researching issues beyond
my expertise and career work in reproductive rights. It was due to this charge as a Network leader that I
became aware of and interested in the Merck& Co.‘s vaccine GARDASIL®. I started paying close
attention to the emerging political, ethical, and efficacy concerns surrounding it. In general, through a fasttracked process, The FDA approved the use of the vaccine GARDASIL® in June of 2006. According to
The FDA press release, “The vaccine is approved for use in females 9-26 years of age. GARDASIL® was
evaluated and approved in six months under FDA's priority review process—a process for products with
potential to provide significant health benefits.”Within a year‘s time, both an energetic advertisement
campaign celebrating ―girl power‖ and buzzing rumor of Merck& Co.‘s aggressive lobbying initiatives for
public school mandates began to surface.
Yet, it was at a Network board meeting, during the Spring of 2007, when I first learned that the
pharmacuetical giant, by way of a bi-partisan lobbying firm, was attempting to legislate compulsory
inoculation requirements of GARDASIL® for girls entering public middle schools. Despite growing
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criticism of Merck & Co.‘s lobbying approach, the District of Columbia lawmakers were on the verge of
implementing such a requirement in their public schools. On the last day of our board meeting, for two
hours, we vigorously discussed the issues surrounding the vaccine, including: the Washington, D.C. case;
the ethics of the lobbying; and the product in general. Our goal was to craft an organizational public
position about the vaccine. Coming up with an organizational statement was critical as many of our
allieswere articulating their positions and were interested in knowing our point of view. One such
comrade, Legal Momentum (formerly NOW Legal Defense Fund), for example, took a strong procompulsory position. They argued that mandatory inoculation would guarantee all girls regardless of
economic status or health insurance status access to this new and expensive women‘s health technology.
Amidst a heated debate, each member of the board and some staff expressed passionately diverse and
valuable perspectives. Those on the board in favor of a mandate shared the views of our allies that
mandates hold the promise of equalizing access to the drug. Those skeptical of such a mandate argued that
a new and fast-tracked drug should continue in the market on a voluntary basis, giving both parents and
girls an opportunity to choose the vaccine. I agreed with the latter point of view, and expressed a desire to
see the vaccine further studied prior to making it a requirement. I also felt that any effort would be in vain
if it does not include comprehensive and far-reaching public education about HPV and cervical cancer,
increased access to cervical screening, and knowledge of vaginal health in general. In the end, we were
quite split as a board but wereable to craft a nuanced perspective reflecting our varying points of view.
That meeting and debate left a lasting impression on me, and I continued exploring the complex issues
that surrounded the vaccine GARDASIL®. Therefore, upon returning to academia in pursuit of a Master
of Arts in Women‘s Studies at Georgia State University, I decided to bring my experience as a women‘s
health advocate, along with my desire to do research, to write about GARDASIL®. Specifically as a
feminist/women's studies project, I became interested in examing the ways the vaccine has been marketed.
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Yet, before exploring the dynamics of the marketing strategies, it is of importance to define human
papillomavirus or HPV, cervical cancer, and GARDASIL® as well as how it works as an intervention.
1.1

What are HPV, Cervical Cancer, and GARDASIL®?

The current studies on HPV state there are approximately 100 different strains of the virus. Fortyof
those strains are linked to sexual transmission primarily through skin-to-skin contact. Of the 40 strains,
strains 16 and 18 have been identified as the most aggressive according to the CDC because they are found
in 70% of the cervical cancer cases.However, it is important to note that most HPV diagnoses are not
strains 16 and 18; as a matter of fact, 90% of HPV cases are less aggressive strains that often clear on their
own. On average 6.2 million new cases of HPV are diagnosed yearly in the United States, making HPV
the most common sexually transmitted infection. In sum, sexually transmitted HPV has about 40 different
strains that are mostly harmless, and while it affects people differently, most infections clear on their own
(Dailard, 2006). However, in certain cases untreated more aggressive strains of the virus have the potential
of turning into cervical cancer, particularly in the absence of regular pap smear screenings.
To date, the most effective way women learn about exposure to HPV and cervical cancer begins with
cervical screening for abnormal cell changes on the cervix through a Papanicolaou test (also called Pap
smear, Pap test, cervical smear, or smear test). If abnormal cell changes are discovered further testing will
be conducted to determine if those changes are due to a HPV infection(CDC).Since the introduction of the
Pap test in 1939 side-by-side with mass public health education campaigns, the incidences of cervical
cancer have drastically declined in the United States. Cervical cancer is typically a slow growing cancer
(CDC), often taking a decade to form. It is due to its slow growing naturealong with prescreening that
often leads to effective treatment and high rates of remission. In the United States, about 11,000 new cases
of cervical cancer are diagnosed every year and between 3,500-4,000 women die annually from the disease
(CDC). Although a cervical cancer diagnosis is quite rare, the womenmost threatened by the perils of
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cervical cancer are uninsured or underinsured women who do not have access to routine screening and
treatments. According to the National Women‘s Health Network fact sheet on cervical cancer,
―Vietnamese American women have the highest rate of any racial or ethnic group followed by Mexican
American, Puerto Rican, and African-American women, whose cervical cancer mortality rate is double that
of White‖ (National Women‘s Health Network, 2007). Again, a cervical cancer diagnosis is unique, yet,
women of color are disproportionately affected and die from it, in part, due to lack of access to culturally
competentquality preventative healthcare. Therefore every death from cervical cancer, in my view, is a
shameful injustice.
In 2006, two multinational pharmacuetical companies launched HPV vaccines with the promise to
prevent cervical cancer. Dispatched first, in early 2006, was GlaxoSmithKline vaccine Cervarix in 27
European countries and gaining patents for the continent of Africa. Stateside, Merck & Co.‘s
GARDASIL® was approved by the FDA by June of 2006. The FDA press release stated:―The vaccine is
approved for use in females 9-26 years of age. GARDASIL® was evaluated and approved in six months
under FDA's priority review process—a process for products with the potential to provide significant health
benefits‖ (http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108666.htm).
GARDISIL® protects against HPV-16 and HPV-18, the strains linked to the majority of the cervical cancer
cases, as well as HPV-6 and HPV-11, which are linked to the majority of genital warts cases. GARDASIL
is an inoculation that requires multiple shots and a half-year commitment. Merck & Co.‘s website
describes how the drug is administered, ―3 injections over 6 months. The first dose at a date a woman and
her healthcare professional chooses. Second dose 2 months after the first dose, and final dose administered
6 months after the first dose, resulting in 3 doses‖ (www.gardasil.com).At the exorbitant rate of $120 per
shot or $360 for the complete inoculation series, GARDASIL® is one of the most expensive vaccine in the
US. To date, 33.3 million doses (and counting) of the vaccine series have been distributed in the United
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States.
Conclusively, HPV is a common sexually transmitted infection with an estimated 80% of sexually
active adults contracting the disease in their lifetime. Most infections clear without medical intervention.
However, in rare cases cancer can occur. The Pap test, along with the development of successful
treatments for abnormal cell development because of HPV, over time, has resulted in dramatically
declining rates of cervical cancer in the U.S. Today, less than 0.01% of cancers are cervical cancer. Yet in
2006, GARDASIL®, a vaccine that protects against four aggressive strains of HPV, was introduced to
consumers through wide sweeping marketing campaigns, in which the rhetoric of its developers positioned
it as the answer to cervical cancer prevention, and positioned cervical cancer as a significant health threat
despite the miniscule numbers.
1.1.1 Research Questions
According to the advocacy organization Pharmed Out, pharmaceutical companies prioritize
―marketing dollars on the newest, most expensive drugs, for which some risks may not yet be known‖
(Pharmed Out and National Women's Health Network, 2008). Again, at the approximate cost of $360
dollars for the vaccine series, the ―approximately 33 million doses sold‖ (CDC, 2011)indicates, for the sake
of this research, a demand for the product due in part, and according to my research findings, to wellcrafted marketing, particularly since the numbers of annual cervical cancer diagnosis in the US are so few.
How does Merck & Co. market GARDASIL®? Arguably, the effective marketing encompasses multiple
aspects including a public health awareness campaign highlighting HPV‘s relationship to cervical cancer.
What are those innovative aspects of the marketing strategies? One such innovation included user-friendly
aesthetically pleasing post-cards that women can send to each other with Merck‘s specific message about
cervical cancer and HPV. These questions, along with Merck‘s newsworthy and controversial lobbying
efforts to secure GARDASIL®‘s place as a public school inoculation requirement, are carefully
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unpacked(Herskovits, 2007), exposed, and explored in this study.
As a method, I used a critical discourse analysis to examine the following three campaigns used to
market GARDASIL®: ―Make the Connection/Charm 4 Life,‖ ―Tell Someone,‖ and ―One Less/ I Choose.‖
Importantly, ―Make the Connection/Charm 4 Life‖ and ―Tell Someone‖ are not advertisements for
GARDASIL®, instead they are public service announcements (PSA‘s) or ―unbranded, disease awareness‖
campaigns (Anonymous, 2008). They were sponsored by Merck & Co. in partnership with two national
non-profit organizations and released nearly a year prior to the vaccine‘s FDA approval. As an indirect
marketing method, these PSA‘s were designed to teach women the link between cervical cancer and HPV
in an effort to prepare the public or ―prime the market‖ (Herskovits, 2007)for Merck & Co.‘s antidote to
cervical cancer—GARDASIL®. Like the lobbying, I will demonstrate that the ―unbranded disease
awareness‖ campaigns were as pivotal to the overall marketing strategy as the award-winning well-known
―One Less‖ commercial campaigns.
Finally, this research project is shaped by my standpoint as a women‘s health and rights advocate.
From this point of view, I situated my research at the intersection of social justice and feminist scholarship
using both black feminist and girls studies theoretical frameworks to illuminate the marketing of
GARDASIL®. Through such an analysis, I give several critiques of the print and television advertisements
focusing on the ways in which race, class, girl power and feminist language are orchestrated to sell the
vaccine. Additionally, I highlighted the specific ways women of color and girls are uniquely targeted and
utilized by the marketing. Centering women of color and girls in this research project is my contribution to
the growing feminist literature about GARDASIL®.
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LITERATURE REVIEW

By definition, pharmaceutical companies engage in researching, producing and selling drugs that treat
and possibly eradicate disease. The combination of pharmaceutical research and drug development sideby-side capital motivations creates a climate of complex ethical issues worthy of being highlighted and
questioned. It is the myriad moral concerns surrounding Merck & Co.‘s vaccine GARDASIL® that is
being contested in the critical writings within varying academic disciplines. For the sake of this research
project, I have identified and read literature on GARDASIL® in public health, medical, law, and feminist/
women‘s studies‘ journals. The articles for each field of study include perspectives that are shaped by the
dominant controversies regarding the vaccine. These disputations have informed the goals of this project
to critically analyze the GARDASIL® print and television advertisement campaigns and are summarized in
this review of the literature.
Drug efficacy and access was prominent in public health and medical articles. According to Adriane
Fugh-Berman, M.D., a contributing writer to the Women’s Health ActivistMarch 2007 issue, ―The vaccine
only works if it is administered before a woman is exposed to HPV.‖ James Colgrove, Assistant Professor
of Socio-medical Sciences at the Mailman School of Public Health Columbia University agrees, ―while the
efficacy rate is about 98% for GARDASIL®, that rate is for women who have not been possibly exposed to
HPV, or, before a woman becomes sexually active. Yet the efficacy rate drastically drops to about 44% in
women who may have had a previous HPV infection, or a sexually active woman who may have been
exposed to the virus unbeknownst to her‖ (Flatow). In addition, the CDC recommends the vaccine to girls
as young as 9 years old, while the Advisory Committee on Immunization Practices (ACIP) recommends
administering the vaccine to girls between 11 and 12 years of age, and again prior to sexual activity. The
Association of Immunization Managers argues for restraint regarding vaccination mandates; in a statement
by the organization, ―Immunization requirements should be used sparingly, approached cautiously and
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considered only after an appropriate vaccine implementation‖ (Wood, 2008). Efficacy issues arise such as,
how long does the protection against the four strains of HPV last? At this time most experts agree that
GARDASIL® provides five years of immunization. Will a booster shot be necessary for further effective
defense? Additionally the recommended age of inoculation is 11 through 13 years of age, mostly because
the vaccine is virtually 100% effective prior to sexual activity. Yet women are at the highest risk of
exposure to HPV between eighteen through twenty-five years of age. Therefore, is it responsible to
inoculate girls as young as eleven if the possibility exists that the vaccine will not be effective at a time in
their lives when they are at the highest risk of contracting the virus? How are young female bodies going
to respond to a drug that was mostly tested on adults?
Another chief issue being discussed is that of access to the vaccine. Once Merck & Co.‘s aggressive
lobbying campaign for widespread public school inoculation requirements along with subsequent bills were
introduced by more than twenty states and were being discussed at large, both the public health and
medical communities weighed in from varying points of view. These views, in certain instances, were
often in direct contrast to each other based on the basic principles that distinguish the two fields.
According to Alexandra Stewart, professor at the George Washington School of Public Health, ―public
health concerns must be weighed against bioethical considerations, which generally place paramount value
on respect for individual liberties, autonomy and the need to obtain informed consent for medical
treatment‖ (Stewart, 2007). In other words, finding ways to democratize access to the vaccine for
under/uninsured low-income young women and girls becomes the priority of public health policy
initiatives, while bio-ethicists are taking, primarily, a precautionary position of maintaining volunteer
inoculation practices while being able to study the young fast-tracked vaccine. A case in point is an article
written in the Harvard Medical School Women‘s Health Watch, which states: ―The new HPV vaccine
shows great promise. Nevertheless, given the many unanswered questions about its effectiveness and
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safety in different populations of girls and women, its use should be more a matter of individual choice
than government mandate‖(Harvard Women's Health Watch, 2007)
Legal and constitutional implications of public school mandate programs for girls were the interest of
some law journal articles regarding GARDASIL®. Scholars were debating, for example, the
appropriateness of a public school entrance requirement of GARDASIL® since HPV is not a virus
traditionally acquired in the public school environment.―Is a state's interest in preventing cervical cancer
for a few, compelling justification to require the HPV vaccination for all?‖ (Wood, 2008) ―Are the means
narrowly tailored and necessary to achieve the compelling state interest, and are they reasonably related to
a legitimate public health objective and proportional to the extent of the harm avoided?‖ (Wood, 2008)
Furthermore, is a gender specific inoculation requirement a violation of women‘s constitutional rights, or is
it necessary in order to meet the specific needs of women? Since women are the only group that can get
cervical cancer, the state has an obligation to secure particular protections for women. In the article
―Protecting Women: A Feminist Legal Analysis of the Vaccine GARDASIL®‖ author Micah Globerson
writes, ―Such a challenge would most likely involve controversial issues of privacy and women's choice
law or equal protection law.‖ Additionally, the Fourteenth Amendment Equal Protection Clause lends to
articulating both a pro and con argument for widespread inoculation of GARDASIL®. Globerson describes
two possible rationales, one favoring each side of the debate: ―One may argue that a vaccination program
directed at girls is similarly susceptible to interpretation as patriarchal, presuming that daughters need
special protection from an STI. Women's unique biology, however, can create an important state interest. If
cervical cancer afflicts only women…the Constitution permits the government to provide a cure to women
only‖ (Globerson, 2007).
Opinions presented in feminist journals, magazines and e-zines opinions vary, yet, overall, there is
optimism about the potential benefits of the vaccine for women and girls. Even more, mainstream feminist
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writings are endorsing the public school requirement programs. The mandates are being interpreted as a
way to equalize access by bypassing the exorbitant price tag of the vaccine and making it available to
under/uninsured girls. Feminists in support of the vaccine requirement are also paralelling it to the need for
comprehensive sexual health education. They are arguing that the vaccine along with sexual health
education can empower youth making safer and astute decision regarding their sexual health. ―We praise
the decision by the Advisory Committee recommending that 11 and 12 year olds be routinely vaccinated,‖
said Julie F. Kay from Legal Momentum,(In Brief, September, 2006). Kim Gandy, former president of
NOW, backs this position by making a bold statement in favor of inoculation requirements in an interview
for the National Now Times, ―The CDC and the FDA made the right decision for women and their
health…They are literally saving women's lives.‖ (National NOW Times, 2007)In the D.C. case,
organizations like Legal Momentum came out strongly for a D.C. requirement believing that it is in fact
due to race and class disparities that African-American girls are at a higher risk for sexually transmitted
infections including HPV, making it necessary for a vaccine requirement.Much of what I read from
feminist health advocacy writings was preoccupied with the politics of the vaccine‘s accessibility.
Therefore, along with debates about economic accessibility are the questions regarding the recommended
age minimum and maximum usage of the vaccine. In sum, those examining the subject of the age
recommendations raised critical questions such as: Does the age cap of twenty-six years old unfairly
discriminate against older women who could potentially benefit from the vaccine? Therefore should the
age maximum be reconsidered and expanded to allow more women an opportunity to choose the vaccine?
And, does the age minimum of 9 years old, with an emphasis on vaccinating girls between 11 and 12 years
of age, need more cautious consideration, especially since there were a limited number of clinical trials that
used a majority adult participation?
GARDASIL® has only been on the market five years yet has drawn interest from a range of academic
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fields raising a variety of ethical, legal, and efficacy questions as previously described. Next I will
expound on the lobbying efforts for mandatory inoculation programs and lift the debates occuring among
those speaking, organizing and writing on the subject. This action by Merck & Co. caused a stir among
various interest groups and resulted in programs in Washington, D.C., and the state of Virginia.Soon
following the Food and Drug Administration's approval of GARDASIL®, in the summer of 2006,Merck &
Co. invested large sums of money towards lobbying law makers to introduce mandatory vaccination
legislation for all girls entering public middle schools. These efforts were headed by a national bipartisan
organization called ―Women in Government‖ (womeningovernment.org) hired by Merck & Co.to promote
the vaccine to lawmakers. In early 2007, this group organized an all expense paid conference in Florida
and invited nearly sixty state legislators to learn about the vaccine. Subsequently, twenty states and the
District of Columbiadrafted bills in favor of mandatory vaccination of school-aged girls.
However, these efforts were slow to bear broad sweeping results with most bills failing to become law.
Yet, on January 9th, 2007 the D.C. Council introduced ―The HPV Vaccination Reporting Act of 2007,
requiring certification that a girl has received the HPV vaccine prior to her enrollment in sixth grade‖
(Stewart, 2007). Subsequently, the District of Columbia became the first city to secure a compulsory
inoculation program in the public school system. Washington D.C. parents pushed-back on the vaccine
mandate, desiring more information about the drug and questioning the public school policy. These efforts
influenced an ''opt-out'' of the vaccine that is included in the D.C. requirement (http://www.dc.gov/DCPS).
Shortly following the D.C. law, the state of Virginia passed a mandate effective school year 2009. To date,
only Washington, D.C. and the state of Virginia require vaccination of GARDASIL® for middle school
aged girls. Yet, experts have noted a difference in the programs of the state of Virginiaversus that of
Washington D.C. According to the Associated Press, ―In Washington, sixth-grade girls will not be allowed
to attend school unless they have had GARDASIL®, or their parents provide the school with a form
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indicating they have opted out. In Virginia, parents are asked to provide documentation if their daughter
had Gardasil, but there is no penalty for not doing so.‖Furthermore, the spokeswoman for the governor of
Virginia, Delacey Skinner, stated to the New York Times, ―the state‘s vaccination program included an
unusually broad freedom to decline the shot‖ (New York Times, August, 2008). Also, a timely pledge
from the pharmacutical giant to expand their local Virginia plant in the winter of 2006 may have also
incentivized the Virginia program.As the aggressive tactics from Merck & Co. to get the vaccine legislated
received negative press, they abruptly discontinued these endeavors. Adriane Fugh-Berman, M.D. states,
―Merck just curtailed its efforts to lobby state legislatures to require vaccination of school aged girls, apart
of which it donated an undisclosed sum to Women in Government‖(Adriane Fugh-Burman, 2007).
Moreover, July 1, 2008, the Federal Government through the U.S. Immigration and Citizenship Services or
CIS added GARDASIL® as one of its inoculation requirements for all women and girls between 11-26 yrs.
of age migrating to this country. GARDASIL® is one of the most expensive vaccines on the market, and
an additional cost burden for women, as opposed to men, navigating the immigration process. ―The
vaccine adds about $375 to the $1,410 cost for applying for citizenship…‖ Additionally, Ana Correa,
executive director of the Texas Criminal Justice Coalition, said, "What we have noticed is that applying for
citizenship decreases as the fees go up," adding, ―I don't think it's a coincidence that they're pushing for a
policy that would provide a burden on immigrants‖ (Kaiser Family Foundation, 2009). In an antiimmigrant political climate, this requirement for women adds another expense, and, subsequently a
potential barrier and deterrent to obtaining citizenship. Yet due to competent activism, largely from
immigrant rights and women of color reproductive justice groups, the federal mandate for immigrant
women was overturned a year after implementation.The lobbying efforts were not in vain; in fact, had they
garnared nationwide vaccination requirement policies the pharmacutical giant would have ensured certain
profits. Suggesting that both proper timing and resources be in place in order for a statewide programs to
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be effective, the National Women's Health Network wrote, ―It is also important to give state legislators and
public health agencies time to allocate appropriate funding to ensure access to the vaccines. The NWHN is
opposed singling the HPV vaccine out for special treatment either because of a corporate profit incentive or
because of the political agenda of abstinence-only conservatives‖ (NWHN).For better or worse, a national
requirement would have guaranteed exposure of the drug to generations of girls to come. These initiatives
were, in my view, part of an overall scheme by Merk & Co. to make the vaccine both accessible and
profitable.
2.1

Conclusion

All things considered, the review of the literature began by uplifting the major issues being written
about Merck & Co.'s vaccinceGARDASIL®. The major areas included ethical, political and efficacy
concerns concentrated in public health, medical, law, social science and some women's studies/feminist
outlets. Many of the articles raised questions such as: Will a booster be nececessary after a number of
years? What are the ethical implications of a for-profit pharmacutical company lobbying for public school
innoculation requirements of their drug? And, what is the response from the public health community?
Once the major debates were acknowledged, the next section focused on addressing the debates occuring
among those speaking, organizing, and writing on one of the dominant and controversial issues—lobbying
for public school inoculation mandates. In the case that Merck & Co.‘s lobbying effort had garnered broad
sweeping school requirements, it would have ensured a critical market of school-aged consumers.
Furthermore, school entrance mandates would have secured GARDASIL®‘s place as a standard part of
pediatric medicine. I conclude this section by arguing that this effort of Merck & Co. was part of an
overall strategyto market and widely distribute their breakthrough vaccine with claims to prevent cervical
cancer.
The background political controversies dealing with GARDASIL® are important to the next
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chapter dealing with the theoretical frameworks guiding this research project—black feminist theory and
girls studies. These two bodies of theory will provide the analytical tools necessary to answer the critical
questions about the ways in which race, class, girl power imagery and feminist language are expressed in
the GARDASIL® television and print advertisements. In my effort to deconstruct these ads, I pose such
questions such as: How many women of color are in the ads? What are they doing in the commercials?
How is class status marked in the commercials? Again, the scholarship addressing GARDASIL® brings to
bear important moral concerns about the young vaccine; yet, too often, this same scholarship ignores how
race and class are used to sell the product. I will address an aspect of this gap through this discourse
analysis project. Black feminist theory and girlsstudies will provide the tools necessary to articulate and
dismantle the hypocrisy of projecting female empowerment in the advertisements, while limiting girls‘
choices through lobbying initiatives for school entrance inoculation requirements.
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3

BLACK FEMINIST THEORY AND GIRLS STUDIES

Black feminist theory and girls studies are the frameworks I am employing in order to more deeply
examine the race and class dimensions of Merck & Co.‘s marketing of GARDASIL® for this discourse
analysis research project. For black feminist theory, the works of scholars Patricia Hill Collins and bell
hooks will provide the analytical tools necessary to successfully assess the expressions of race and class in
the Merck HPV/cervical cancer and GARDASIL® advertisements. For example, Patricia Hill Collins
writes in her groundbreaking text, Black Feminist Thought: Knowledge, Consciousness, and the Politics of
Empowerment, about ―intersectionality‖ a concept that suggests that in the lives of Black women, issues of
race, class and gender often work in concert(Hill-Collins, 1991). Applying the idea of intersectionality to
this discourse analysisprovides my critical writing the flexibility to consider how race and class overlap
and are used to show ―real‖ and therefore relatable women and girls using and endorsing Merck's vaccine
GARDASIL®. Next, the emerging field of girls studies offers the analytical tools to uplift and understand
the particular issues of girls regarding the politics of GARDASIL® since they are a vital demographic for
Merck. Ironically, in the ethical, legal and efficacy debates surrounding GARDASIL®, girls‘ voices were
absent. Even more, within mainstream feminist analysis of the politics of the drug, an air of paternalism
can be assessed as few feminists askgirls how they feel and think about GARDASIL®. Particularly in the
case of the proposed mandatory vaccination programs in public schools,girls‘ points-of-view are absent.
Girls studies‘ scholarship centers girls‘ realities by providing the necessary theoretical language that fills a
gap left by mainstream feminist perspectives on GARDASIL®. For example, girls studies effectively
identify and critiques destructive binary ideas about girls such as the ―can-do‖ girl and the ―at-risk‖ girl. I
found these terms useful in this research project because they are names for western cultural attitudes about
girls. Furthermore, these notions about girls are, I assert, embedded in the successful GARDASIL®
marketing campaigns. Therefore, integrating girls studies in order to explore the use of these concepts
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within the marketing will allow for a deeper analysis than black feminist theory could successfully do
alone.
3.1

Black Feminist Thought/Theory

Largely, black feminist thought/theory is the project of distinguishing the knowledge production of
African-American women based on their uniquely situated experiences primarily shaped by race, class,
gender, and sexuality oppressions in the United States of America. Patricia Hill-Collins describes the
features of black feminist theory and research in Black Feminist Thought: Knowledge, Consciousness, and
the Politics of Empowerment as not different to other bodies of research, yet it is distinguishable at the
location which these features intersect. The features of black feminist theory relevant to this project are
described below:


Identifying and articulating different forms of oppression that disproportionately affect women,
and crafting activist tools for empowerment and liberation.



Acknowledging a matrix of domination that dictates that, in the lives of Black women, issues
of race, class, gender, sexuality, and nation often work simultaneously to create a unique lived
experience that can only be understood inside the simultaneous complexities.



At the onset of research, not privileging any particular ‗ism‘ but rather discussing the hidden,
insidious ways they work together.

After observing numerous GARDASIL® television and print advertisements, I found that women of
color are often prominently placed within the commercials. Smartly, the three marketing campaigns are as
much racially diverse as they are racially targeting. What does that mean? Merck& Co. launched a savvy
girl empowered media campaign soon following the FDA's approval of GARDASIL® in the summer of
2006. This prominent award winning ―One Less‖television commercial showcased a multi-racial bevy of
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working and middle class looking young women engaged in various activities. Appearing as a politically
correct girl-power commercial, it includes a Caucasian girl skateboarding, a group of young Latinas
playing basketball on an inner city basketball court, African-American teenage girls practicing their
choreography, and, in the final scene,a different group of African-American teenage girls jumping doubledutch rope on a city sidewalk while chanting the commercial's tagline: ―I will be one less, one less! O-N-EL-E-S-S, I will be one less!‖ According to Bitch Magazine, the One Less commercial is comparable to that
of the Nike ―Just Do it!‖ campaign since it is―produced in the same slick but calculatedly edgy aesthetic of
Nike commercials from the late 1990‘s‖ (Kessler & Woods, 2007). Like the Nike commercials, ―One
Less‖ presents female actors as strong and powerful through the act of playing sports—hence, it implies
that they are motivated to make smart choices about their health by getting vaccinated with GARDASIL®.
Carefully, racial diversity is infused throughout the ―One Less‖ commercial, while the African-American
girls are prominently placed towards the end. Their pronounced positioning in the television advertisement
is demonstrated in two ways: first, they have the greatest number of actors relative to the other group of
girls and they are the last voices and faces in the commercial chanting the product tagline. The AfricanAmerican actresses‘ enthusiasm becomes the last impression the viewing audience has of the drug. In a
Spanish speaking ―One Less‖ commercial, called ―Una Menos‖ a young Latina is drumming while
endorsing the vaccine in one scene, in the next, both a mother and daughter prepare for a quinceañera. The
commercial culminates with a young flamenco dancer practicing in a dance studio. These actors are meant
to representthe Latino community. Through the use of racial and cultural signifiers demonstrated by the
actors, the product, in this instance, the vaccine GARDASIL® becomes culturally relevant, and the
manufacturer appears to understand this community and have their interest in mind. For marginalized
communities, target marketing is particularly significant because, often, the consumer marketing
experience is shaped by the interest and realities of the majority white cultural ideals and does not reflect
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the community of colors‘ realities. However, vigilance is required in these moments of cultural awareness
in mass product marketing campaigns—a vigilance from those communities being targeted to consider the
agenda and rationale guiding the specific marketing, and, as consumers, what is important to understand
about the pro‘s and con‘s of the product—and not to relax vigilance based on the marketer‘s consumption
and subsequent projection of relevant cultural markers. Therefore, while Black feminist theory prioritizes
African-American women‘s experiences, the analytical features are transferable to support my critical work
of looking at how all women and girls are to be understood in the advertisements, while centering the
particular ways women of color are represented. Black feminist theory allows for what I am calling a
―layered approach‖ to analysis. The layered approach allows for the flexibility to examine the nuanced
themes being replicated in the GARDASIL® advertisements. In other words, the subtle subtext is
appreciated and discussed as important to the ways that it shapes the overall projected message.
Delving further, I researched articles containing interviews of the representatives from the marketing
firm that created the ―One Less‖ commercial brand—DDB. The following quotes, lifted from these
interviews, describe the design process of the One Less commercial campaign. These statements indicate
to me, as a Black feminist researcher, insight into theconscientious effort to use race and class in the design
of the commercials. According to one DDB representative, ―Bev (referencing Beverly J. Lybrand, Vice
President and General Manager, HPV Franchise, Merck Vaccines)urged us to go through all of the faces
and ask whether they were expressing what we wanted them to‖(Applebum, 2007).This quote raises
interesting questions. For example, what faces would best represent the product? What kind of expressions
would best convince the viewing public that they should get vaccinated with GARDASIL®? The DDB
representative continues, ―That led to some changes in the people used in the advertisements. As a result,
we created a much stronger message of empowerment‖(Applebaum, 2007). Third wave feminist magazine
Bitch, while critical of the One Less commercial, agreed with the advertiser's assessmentby calling it ―the
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most feminist friendly ad campaign in recent memory.‖ While I do not know what ―faces‖ DDB was
originally considering for the commercial, what is for sureis that the faces and bodies that are used in the
commercial campaigns feature working/middle class young women of color and young white women.
Again, the DDB representative describes the design of the prominent ―One Less‖commercial: ―Filmed in a
gritty, documentary style, the ads intersperse information about GARDASIL®between scenes of teenagers
at play or hanging out on city streets.‖ To that end, racial diversity concurrently with class uniformity
becomes a crucial factor to developing the brand concept. In ―Eating the Other: Desire and Resistance‖ in
Black Looks: Race and Representation, Black feminist scholar, bell hooks, helps untangle the above quote
and understand the psyche of American consumption culture and its obsession with the exotic ―other.‖
hooks states, ―As often is the case in this society, they were confident that non-white people had more life
experience, were more wordly, sensual,and sexual because they were different‖ (hooks, 1992). In this
instance, these actors represent young women who are to be understood as havingthe life experiences that
warrant the vaccine.While many of the commercials may open with a young white woman speaking about
the vacinne, as the commercials continue brown and black faces become quite key. Again, hooks writes,
“Within commodity culture, ethnicity becomes spice, seasoning that can liven up the dull dish that is
mainstream white culture.‖Moreover, language such as ―gritty,‖―street,‖ and ―hang out,‖as stated in the
DDB representative's quote, evoke in the mainstream imagination/viewing audience both the racial identity
and economic status of these girls as among the poor and working class.Class status is marked in several
ways in the commercial including: the urban background; the activities the girls are engaged in, such as
basketball and skateboarding; and the overall style of the young women actors. City youth in America are
notoriously and often portrayed in media as in constant need of state surveillance and intervention by way
of the criminal justice, welfare, or public health systems. Therefore in the commercial, the actors‘
empowerment is in part due to their choice to be unlike other ―city‖ girls by taking control of their sexual
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health and getting vaccinated with GARDASIL®.
Furthermore, the introduction of a GARDASIL® vaccination requirement for 6th grade girls attending
Washington, D.C. public schools, in which79% of the student population is AfricanAmerican(www.dc.gov/DPS/), brought to fruition important questions among the African-American
community about the efficacy of the new drug, and the necessity of a school entrance requirement. The
mandate triggered historical concerns of the exploitation of African-American bodies in medical
experimentation as well as racist notions of African-American women‘s sexuality. ―In a controversial
Washington Post opinion piece, Courtland Milloy writes that the DC proposal to vaccinate girls in school is
built on this notion: ‗After all, your daughter is 11 and probably black, so the assumption is she‘ll be
having unprotected sex in no time – but don‘t take offense…And please don‘t bring up that old paranoia
about government agencies conducting medical experiments on black people‘‖(Milloy, 2007). While I
think much of what Milloy wrote was brash, it tapped into some of the underlying concerns of AfricanAmerican families with daughters attending school in the District of Columbia. These were complicated
issues that evoke both race and class anxieties perhaps embedded in the public health policy response in
D.C. However for those working in public health, including some prominent women of color healthcare
providers and advocates, supporting the mandate was in part due to a desire to decrease young women‘s
exposure to HPV and, possibly, invasive and painful treatments. Again, it employs the assumption that a
mandate would be the only way underserved girls in D.C., who are primarily African-American, would
have access to this new health technology. African-American women‘s health, especially their sexual and
reproductive health, has always been a source of public debate and, at times, has met unfortunately with
unethical experimentation and treatments that in the end were found to be detrimental. However, I agree
with the words of African-American medical journalist Harriet A. Washington, author of the
groundbreaking text Medical Apartheid: The Dark History of Medical Experimentation on Black
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Americans from Colonial Times to the Present, as she both writes about the medical atrocities since
enslavement to African-Americans and encourages African-Americans to get involved with ethical clinical
trials. She writes, ―But medical abuse is more than historical fact…The challenge is to prepare the way for
a new openness to medical research on the part of African-Americans while maximizing their protections
from abuse‖ (Harriet, 2006). Black feminist thinking and vigilance is necessary in this case. It is
important to incorporate an understanding of ―intersectional‖ realities in order to effectively monitor
pharmaceutical drugs targeted towards African-American women, while ensuring that African-American
women have access to the latest technologies.
In sum, commodifying and displaying racial diversity and class uniformity, under the guise of
celebrating girls' empowerment, is part of the―One Less‖GARDASIL®commercial design. Even more, the
creative approach described by the marketing firm DDB, including use of the descriptions ―gritty‖ and
―street‖ affirms my assessment of the commercial‘s use of race and class along with mainstream societal
notions of the kinds of girls who are ideal candidates for the vaccine. In the next section of the review, I
will consider “girl power‖ as another key strategy of the advertiser to market the vaccine to girls and young
women. Additionally, girl power is important to the marketing because it shows girls and young women,
confidently and with the support of their mothers, ―choosing‖ this product. Therefore ―girl power‖ needs to
be explored as an ideal value for girls re-imagined for marketing purposes, as is the case with
GARDASIL®. As a Black feminist researcher, it is important for me to uplift the issue of bodily
autonomy and integrity of girls in this project,as girls are the primary targeted recipients ofthe vaccine
GARDASIL®.
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3.2

Girls studies/ Girl Power/ Can-Do and At-Risk

For the most part, girls' perspectives on the vaccine are missing from much of the critical literature
written aboutGARDASIL®. This is an unfortunate finding given that the vaccine is FDA approved for girls
and young women as young as nine years old and recommended for girls between eleven and twelve years
old. Therefore girls areimportant consumers to the manufacturerer. For those researchingGARDASIL®
from a feminist or social science perspective, listening to and learning from girls about the vaccince will
bring a depth to the overall critical knowledge being produced. While this project does not include
interviews of young women and girls, thissection will use analytical concepts from girls studies to explain
why marketing directly to girls and young women is a necessary part of the marketing strategy. I will begin
with ―girl power,‖ a third wave feminist ideal that is often co-opted for commodity interests as is the case
with the GARDASIL® commercial campaigns. Next I will look at the concept of the ―can-do‖ and ―atrisk‖ girls from writer Anita Harris in her work, Future Girl(Harris,2004). This text identifies the binary of
can-do and at-risk as a device to socialize and control girls‘ lives. I will then show how both the ―at-risk‖
and ―can-do‖ girls are the aim of Merck & Co. through their marketing and lobbying efforts. Finally, I will
critique paternalism and how that affects and silences girls‘ voices from this debate. Ultimately I will
make the case that while parents or guardians—especially mothers are the ones who often decide for girls
and young women to get the vaccine, the marketers do not take for granted that they must sell this product
to girls. This understanding is displayed through a girl-centered, feminist marketing campaign that
includes an interactive website, bracelets, and an abundance of girls and young women represented in the
commercials and print advertisements. It is, therefore, necessary to center girls‘ experiences and voices
regarding this drug.
Girl power is defined as ―young women‘s scope for own decisions: the ability of or opportunity for
teenage girls and young women to make decisions for themselves and shape their own lives‖ (Encarta
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World English Dictionary North American Edition).It is considered an aspect of third wave feminism, and
the term is reported to become a part of the mainstream lexicon by the mid to late 1990s as it was adopted
by mainstream media and marketing industries to sell products to girls. The messages of female
empowerment through these media representations of equality or ―girls can do what boys can do‖ appeared
to be positive messages for girls. In the article ―Young Women and Consumer Culture: An Intervention,‖
Angela McRobbie writes, ―Within the last decade a substantial sector of the commercial domain has
embraced notions of gender equality (―the pretense of equality‖ as Jean-Luc Nancy would have it) and has
used this ideal as a means of generating and disseminating more energetic, confident and assertive accounts
of girlhood and young womanhood‖(Jean-Luc Nancy, 2000;McRobbie,2008).However, this ―can-do
attitude‖ promoted through various popular cultural outlets maintain and satisfies the heteronormative
patriarchal visual appetite, as many of the images of young women are as naive hyper-sexualized eyecandy. The messages designed to inspire girls to be self-assured, simultaneously, do not encourage girls to
question systems of inequality or offer information about how to change these systems. Instead, these are
corporate capital driven messages informed by extensive market research that understands that girls are
vital consumers. The consumption-based empowerment messages for girls are often about personal
improvement or development through education, self-esteem, and physical activity. These are critical
lessons for success however they situate the fate of all girls at the feet of each girl and her family. The state
and corporate driven capital entities that target girls through policies or marketing are simultaneously
excused from responsibility and accountability to the state of girls or their futures. Families are often
figuring out, in a competitive society, how best to get an advantage that ensures future success in the face
of gender-based obstacles. The answer is, of course, that being commodity-driven and a willing consumer
is the proper attitude. A narcissistic, capital driven self-esteem is fed in abundance to girls, through
popular media emphasizing success through achieving physical beauty, being an ideal student, and model
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―citizen‖ by following the rules (of the state) and not questioning or rebelling against them. At the same
time, those feminist spaces interested in supporting girls‘ questioning sexist norms and advocating social
justice are often frowned upon and deemed anti-men, too ―radical,‖ and subsequently marginalized.
In 2006, Merck & Company followed suit with their brand of girl-power marketing of their vaccine
GARDASIL®. Reinforced through firm statements and confident demeanors, the young women actors and
models engage in various sports or activities throughout the commercial and print advertisements. Infusing
physical activity with consumer-directed pharmaceutical advertisements is not unique to Merck‘s ―One
Less‖ GARDASIL® campaign. As a matter of fact, it is a calculated strategy of the creators of this form of
marketing. ―More than one half of [direct-to-consumer pharmaceutical] ads (52.7%) showed the primary
character engaging in some physical activity. Eighty percent of these ads showed characters engaging in
moderate or vigorous physical activity.‖ (Frosch et al., 2007) Reminiscent of liberal feminist rhetoric that
speaks of equality and bodily autonomy for women, the ―One Less‖ slogan reinforces these values by
encouraging young women to take control of their health with their product. Girls‘ declare, ―I will be (One
Less)—one less statistic, and one less woman who will die from cervical cancer because I choose to get
vaccinated with GARDASIL®.‖ In this instance, by choosing to get vaccinated with GARDASIL®, these
young women are making, according to the advertisement, a wise and empowered decision for their health.
It becomes an ―empowered‖ decision because, according to the advertisement, young women ―choose‖ the
vaccine. Furthermore, the ―I choose to be one less‖ tag-line evokes feminist stances regarding reproductive
―choices‖ and, hence, bodily freedom from patriarchal state control. Bev Lybrand of Merck & Co.
reinforces my analysis in the following statement about the message of the ―One Less‖ commercial, ―The
idea was really to deliver on the strong and powerful message of empowerment‖(Herskovits, 2007).
―One Less‖ and the other HPV commercial campaigns from Merck & Co. use highly sophisticated girl
power images paying close attention to cultural and racial diversity. Simultaneously, the young women
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actors in the ―One Less‖ commercials perform within racially and economically expected activities, such as
the Caucasian teenage girl skateboarding and the Black teenage girls jumping double-dutch rope. The
statement being made through the display of activity is these are sports that ―real‖ girls participate in.
Therefore through savvy marketing, girl power is updated and projected to sell Merck & Co.‘s vaccine to
concerned mothers, young women and girls. Feminist scholars have coined this as commodity or popular
feminism, and ―girl power‖ is one tool. McRobbie summarizes this analysis with the following statement,
―This usage of feminism (in its most conventionally liberal feminist guise) also provides corporate culture
with the means of presenting itself to young women as their ally and even champion of ‗girls‘ while at the
same time earning seeming approval for adopting the mantle of social responsibility‖ (McRobbie,
2008).This is true for GARDASIL® and Merck & Co., whose public relations machine was able to
position the vaccine as a breakthrough in women‘s health and the answer to cervical cancer prevention.
Even with fast-tracked FDA approval and limited clinical trials, GARDASIL® was endorsed and promoted
by some national feminist organizations like Planned Parenthood and feminist media outlets like Ms.
magazine. Merck & Co., in this case, positioned itself as the ally of feminists. Their girl power message
was well received, while, ironically, girls‘ empowerment was being limited through Merck & Co.‘s actions
of lobbying for mandatory school inoculation programs, particularly in the case of Washington, D.C.,
where an innoculation mandate is in place for all girls entering the sixth grade and 79% of the student
population is African-American (www.dc.gov/DPS/).Therefore, African-American girls‘bodies, in this
instance, are unapologetically and disproportoinately affected by a mandatory inoculation policy, yettheir
points of view of the vaccine are missing from thecritical literature.Commercial versions of girl power
from many corporate entities are designed to display an image of equality for a profit, while minimally
investing in efforts to eradicate institutional inequalities. In this instance, Merck & Co.‘s GARDASIL®
advertisements do not encourage girls to get involved in efforts to increase their knowledge about the
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health issues that disproportionately affect them such as the human papillomavirus and cervical cancer.
Instead the message is that their empowerment is contingent upon their bodily compliance to the
Protector/Father/Superhero vaccine: GARDASIL®.
Notably, in 2009 GARDASIL® was approved by The FDA for boys and young men between 9-26
years old. Yet there has not been the equivalent amount of pervasive marketing campaigns encouraging
young men and boys to get vaccinated with GARDASIL® or convincing their parents that it is a necessary
part of their son‘s healthcare. Additionally, there has not been a reporting of a major lobbying initiative to
legislate 11 and 12 year-old boys‘ bodies with the vaccine. As a matter of fact, recommendations from
expert medical agencies‘ language read quite differently for girls and young women versus boys and young
men. Merck& Co.‘s GARDASIL® website adds the CDC‘s recommendations for these two groups. The
website states: ―The Centers for Disease Control and Prevention (CDC) recommends routine vaccination
with GARDASIL® for girls ages 11 to 12, and for young women ages 13 through 26 who have not already
been vaccinated. The CDC states that GARDASIL can be given to boys and young men ages 9 through 26,
if you and the doctor decide it is right for your son‖ (www.gardasil.com). For girls and young women, the
CDC is reported to recommend ―routine vaccination‖ with GARDASIL®, while for boys and young men
GARDASIL® ―can be‖ used, ―if decided…it‘s right for your son.‖ Both young women and men can get
HPV and spread it to others primarily through skin-to-skin contact making HPV the widest sexually
transmitted infection. The recommendations for young women and young men, at a minimum, should be
the same, especially considering that women have a first-line of defense against cervical cancer through a
Pap smear examination detecting abnormal cells potentially linked to HPV, while there is no routine
prevention exam equivalent for men. However, men could be susceptible to getting sexually transmitted
HPV infections like genital warts or some cancers such as anal and throat possibly caused from an
untreated undiagnosed HPV infection. Perhaps young men and boys should be equally asked to consider
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GARDASIL® as part of their preventative health routine. However this is not the case; instead women and
girls are rigorously marketed to and, in some instances, required to get the vaccine. Dealing with the
differences between marketing strategies for young women and men of GARDASIL® is not the crux of
this research project. This digression, however, was necessary in order to illuminate the ways in which the
private and public sector can work in tandem to privilege men while undermining women and girls
decision-making about their bodies under the guise of celebrating women‘s empowerment through the
advertisements.
The print and television commercials have a formula that includes racial diversity, working and middle
class uniformity couched in a message of empowerment through ―girl power‖ imagery. Now, I will
consider how this formula to widely distribute the vaccine is deployed in ways that understands girls in two
categories—―can-do‖ girls and ―at-risk‖ girls. Can-do and at-risk girls are categories explored at length by
writer Anita Harris in the book Future Girl. Harris writes about girls living in modern western societies and
how these societies assign binary categories such as ―can-do‖ and ―at-risk‖ in which different paths are
established to engage each type of girl. Often, this binary of can-do and at-risk are established early in
girls‘ lives based on a range of demographic factors, including race, economic status, and geographical
location. These demographic factors also inform societal stakeholders such as social scientists, policy
makers, public health officials, medical practitioners, ―tax paying‖ citizens, and educators about how to
engage each category of girl. Most importantly, these narrow boxes for girls allow for a system of
surveillance and control of girls‘ mental and bodily integrity. Moreover, and according to Harris,
surveillance and punishment of girls is increasing as an effect of rapidly growing and reconfiguring market
economies. The encroaching privatization of public spaces and institutions are forcing girls (Hendrixson,
2002)into narrower spaces in which to grow and develop. For example: increased privatization of education
opportunities, fewer jobs, continued wage disparities, increased restrictive and penalizing policies on
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reproductive health care, and punitive drug policies are making it difficult for certain girls to matriculate
successfully within society. Harris states that girls are being presented as the ―vanguard of a new
subjectivity‖ (Harris, 2008) or a site to mark societal progress and societal decline within the neo-liberal
narrative of the United States of America. In general, and for the purposes of this study, historically the
can-do girl is shaped in the dominant imagination as middle class, able-bodied, virtuous, and
heterosexual—a White ―girl scout.‖ The at-risk girl is shaped in the same dominant cultural imagination as
promiscuous, lacking virtue, poor, and of color—particularly Black and Latin—and a delinquent.
Furthermore, the can-do girls are expected to excel in education, be civically engaged, and hold off
reproduction until marriage. At the same time, the at-risk girls are expected to have limited personal goals,
reproduce early, and be in constant need of state intervention and assistance. These categories work in
concert to regulate both outside and inside populations of girls, as well as have girls self-regulate in order
to fit cultural ideals girlhood.
Merck deploys this logic through the ways in which it sells its HPV vaccine GARDASIL®. The
campaigns, with their girl-power inspired themes, show at-risk girls turned can-do girls by using their
product—while inoculation mandates of their vaccine target the at-risk girl. In other words, both categories
of girls become important to the multi-national pharmaceutical giant as consumers of their product. The
racist and classist depiction of the at-risk girl is interrogated in the essay ―Superpredator Meets Teenage
Mom: Exploding the Myth of Out-of-Control Youth‖ (Hendrixson, 2002). The article highlights youth
crime and teen pregnancy are on a decline in the United States of America, yet casting youth as out-ofcontrol and sexually deviant remains the dominate narrative. This national context about youth and youth
sexuality, in the case of Merck & Co.‘s HPV vaccine GARDASIL®, is profitable and allows them to
participate as allies of society by vaccinating girls and preventing the spread of disease—sexually
transmitted disease. While there are those who have criticized the expensive price-tag of approximately
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$360 for the inoculation series, Merck has responded with a vaccine program for financially disadvantaged
at-risk and young women and girls. By going to Merck‘s website and clicking on the ―Merck Vaccine
Patient Assistance Program‖ one can find instructions (side-by-side with a picture of a young AfricanAmerican woman) as to how to access GARDASIL® with minimal requirement for the economically
disadvantaged. The following qualifications are as stated on the website:


You reside in the United States and are age 19 or older*You have no health insurance coverage.
(Some examples of health insurance coverage include private insurance, HMOs, PPOs, college
health plans, Medicaid, Veterans' assistance, or any other social service agency support.)



Individuals who do not meet the insurance coverage criteria may still qualify for the vaccine
program if the patient has special circumstances of financial and medical hardship. You do not have
to be a U.S. citizen.



You have an annual household income less than:
o $43,320 for individuals
o $58,280 for couples or
o $88,200 for a family of four
(http://www.merck.com/merckhelps/vaccines/qualify.html)

The HPV vaccine is also available through the federal Vaccines for Children (VFC) program. VFC
provides vaccines for children ages nine to eighteen that are covered by Medicaid, Alaskan-Native or
Native American children, and some underinsured or uninsured children. As a federal program, tax dollars
are used to ensure the availability of the vaccine within the fifty states. While positioned as an altruistic
gesture—access to the vaccine to low income, undocumented, or at risk populations of girls and young
women, at approximately $360 per dose per girl, with federal subsidies—Merck is still benefitting from
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serving this population. Again, the state creates ways to control girls‘ sexuality and bodies, in many cases,
with the complicity of guardians/parents. Adults who are often well-intentioned and trying to make a
decision to vaccinate their daughters with GARDASIL® are navigating a substantial amount of
complicated information about the vaccine along with the manufacturer‘s claim of protection against
cancer. Therefore, many parents rely on the analysis and recommendations of doctors, government
agencies, and the information being supplied by the pharmaceutical company to be accurate. It must be
stated, however, that many parents raised questions about the vaccine and pushed back on school entrance
requirements of GARDASIL®. This response from parents was in part the motivation for Merck & Co. to
cease their lobbying initiatives.
Moreover, mothers in particular become an important part of Merck & Co.‘s ability to sell the vaccine
in subsequent GARDASIL® commercials. Getting mothers excited about the vaccine by focusing on the
message of cancer prevention, instead of the uncomfortable conversation of sexually transmitted HPV, the
commercial uses ―mothers‖ to encourage viewing mothers to protect their daughters from cancer. Mothers
of all races are seen in the commercial talking or engaged in some fun activity with their daughters and
having a serious conversation about the vaccine including the potential side effects. Extensive marketing
research has shown that when a mother talks to her daughter about GARDASIL®, both proactively and
favorably, a girl or young woman is more apt to get vaccinated. ―The research, published in the journal
Human Communication Research, zeroed in on 182 mother-daughter pairs. The daughters — college
students whose average age was 20…Most of the pairs — 137 — reported talking about the vaccine…what
tipped the scales regarding a daughter's decision to get vaccinated? A mom who shared that she thought the
vaccine was a safe and effective way to prevent HPV‖ (Rochman, 2011). Merck understands that getting a
daughter or young woman vaccinated is often a family decision, and therefore it is vital to have young and
mature actors in the commercials, in unison, speaking highly of the vaccine. This projection of mothers
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and daughters getting along and working together is a major component of what makes this commercial
campaign largely viewed as female friendly. Beth Herskovits writes, ―The disease awareness effort did
more than just play on cancer fears, but drew on themes of safeguarding your children (for moms) and
empowerment (for girls).‖She goes on to quote Bev Lybrand, Merck's vice president and general manager
for GARDASIL®: ―Of course everyone understands cancer and is scared of cancer, but we learned early
on that moms really wanted to protect their daughters—that protective insight is important. For young
women, they want to empower themselves to take control of their own destiny‖ (Herskovits, 2007). Rarely
do media-makers create images and or storylines of mothers and daughters getting along, let alone on a
subject that is as taboo as sexual health. Yet, Merck is able to actualize this, by glossing over the sexual
health aspect of the vaccine and focus on the message of cancer prevention. The appearance of the ideal
mother and daughter relationship projected in the GARDASIL® commercials through the ability to talk
about such a serious issue makes these women the envy of women viewers who desire to have this bond
with their daughters. Again, this is an important alliance for Merck, yet girls‘ perspectives and bodily
autonomy is compromised, subsequently, when the adults are making the ultimate decision for their lives.
Finally, girls are entering the debate on GARDASIL® marketing through innovative uses of
technology. Parodies of the GARDASIL® commercials created by teen girls via ―YouTube‖ are
demonstrating a resistance to the girl power/ girl friendly messages Merck is attempting to present. These
videos are critiquing the ways in which girls are often underestimated in knowing the politics and
controversies surrounding the vaccine. For example, in the ―YouTube‖ video discussed in this research,
the young woman actor plays an exaggerated version of a naïve girl who proudly states that she has done as
she was told according to Merck & Co. ad and got vaccinated with GARDASIL®. In the final chapter, I
have included one video and one print ad parody showing young women ―talking back‖ to the patriarchal
and ageist corporate stakeholders. These young women are demonstrating a critical perspective towards

34

the multi-million dollar female friendly marketing. They are raising critical questions about the efficacy of
the vaccine and a society that makes decisions about their bodies without their input.
3.3

Conclusion of Black Feminist Theory and Girls Studies

This theoretical framework chapter demonstrated how black feminist theory and girls studiesprovided
the analytical tools necessary to grapple with the focus of this research project, analyzing how
representations of race, class, and girl power are used in Merck & Co.'s innovative consumer marketing
campaigns. Black feminist theoryprovided the concept of intersectionality to be able to effectively consider
howrace and class are used in the marketing campaigns. Distinguishing various forms of oppression
allowed me to center the issues of race and class in my critique of the advertisements instead of making
these an appendage as in other critical work on GARDASIL®. Black feminist theory moves issues of race
and class from the margins to becoming a vital aspect of research. However, within feminist spaces, a
paternalism in the rhetoric about the politics of the vaccine do emerge. Few feminists asked—how do girls
feel and think about GARDASIL®? Therefore, feminist theories alone donot get at the importance of girls
as a target market. Thus, incorporating the scholarship focusing on girls allowed me to articulate the ways
in which marketing to girls is important to the manufacturer. In much of the literature written about
GARDASIL®, how race and class are used in the marketing campaigns arenot a priority of the work;
similarly here it requires the simultaneous use of black feminist theory and girls studies theoretical
concepts to effectively analyze the deployment of girls‘ intersectional identities in the marketing of
GARDASIL®. In this instance, race and class are vital to critiquing the advertising campaigns of
GARDASIL®. Therefore, as a feminist researcher, I have distinguished the themes in the marketing
strategies of Merck & Co. that target girls, young women and mothers.Racial diversity along with
athleticism among the young women actors in the ―One Less‖ commercial campaign evoked ideals of
empowerment. These young women are unified because each made a smart and choice to protect her body
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with the vaccine GARDASIL®. This girl power imagery along with and feminist friendly taglines was
Merck & Co.‘s strategy to promote their vaccine GARDASIL®. Lastly, I examined, what Anita Harris
calls ―can-do‖ and ―at-risk‖ girls. The western societal binary construction of girls creates a system of
control and surveillance. I was able to take the definitions of each category and demonstrate the ways in
which distributing GARDASIL® used these polarizing attitudes towards girls to distribute the vaccine to
girls.
In the next chapter, I identify and provide an account of the development of Merck & Co.‘s HPV
awareness and, ultimately, GARDASIL® commercial campaigns. I give a critique of the print and
television advertisements focusing on the ways in which race, class, girl power and feminist language are
orchestrated to sell the vaccine GARDASIL®. The prevalent arguments have been introduced and
summarized in the previous chapters. I am, therefore, connecting the print and television advertisement
campaigns and the lobbying efforts as tactics working side-by-side to widely distribute and sell the vaccine.
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4

MARKETING CAMPAIGNS AND THE RESEARCH METHODOLOGY

In 2005, Beverly J. Lybrand, Vice President and General Manager, HPV Franchise, Merck
Vaccines,discussed in an interview Merck‘s marketing research conclusions. What they found was that
less than 20% of U.S. women knew the link between cervical cancer and HPV. Stated differently, 80%, or
the majority of US women, were unaware of this connection. For Merck & Co.,this was an opportunity to
become the public authority and compassionate voice on the subject of HPV and its link to cervical cancer
through public health education messages. Lybrand stated, ―After discovering the tremendously low
awareness, communicating the link between HPV and cervical cancer became the primary focus of the
campaign‖(Herskovits, 2007). Therefore, over one hundred million dollars was allocated to conduct HPV
and cervical cancer link outreachsponsored by Merck and partnered with non-profit advocacy
organizations: Step Up Women‘s Network and the Cancer Research and Prevention Foundation(Blum,
2006). These women-centered organizations‘ names and logos became the branded look of this public
health outreach initiative. This important partnership both validated and allowed for Merck‘s women‘s
health message to go directly to women through the organizations‘ outreach initiatives, such aspublic
service announcements, bracelets, postcards, and interactive websites designed to tellwomen and girls that
a ―common virus‖ or HPV was the primary link to most cervical cancer cases. At the same time, these
campaigns did not tell women about how to reduce the risk or prevent HPV. As a matter of fact, the
outreach campaigns offered little to no solution except to instruct women to inform other women that HPV
is linked to cervical cancer and to talk to their doctors. The Merck funded PSAs which are the focus of this
research project are titled―Making the Connection‖ and ―Tell Someone.‖Saturating various media outlets
for approximately one year, these two campaignsarguablywere developed to ―prime the market‖ or prepare
consumers for the FDA's approval of the vaccine GARDASIL®(Herskovits, 2007)(Rose, 2002). In June of
2006, the FDA approved the use of GARDASIL® for girls and young women nine through twenty-six
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years old. Soon following, an energetic girl power multi-media campaign, ―One Less,‖ emerged with a
racially diverse cast of young women and mothers celebrating the solution to cervical cancer—
GARDASIL®. ―Make the Connection,‖ ―Tell Someone,‖ and ―One Less‖ print and television
commercials had a narrativethat built on each other. This narrativebegan with revealing that HPV is
connected to cervical cancer. Once women were so informed, the next commercial campaign instructed
women to share the responsibility ofthis newfound information with other women. Lastly, a powerful
advertisement campaign celebrating the answer to cervical cancer prevention wasintroduced by Merck
which is GARDASIL®.
The methodology used in this research project is discourse analysis. This method allowed me to
evaluate and write critically about the ways in which race, class, girl power, and feminist language are used
in the advertisement campaigns. I studied three commercial campaigns by centering the visual images and
words produced for the campaigns. I linked this analysis of the images with the larger ethical and political
questions occuring in the literature surrounding GARDASIL®. Additionally, as a feminist discourse
analysis project, I used Gillian Rose‘s text, Visual Methodologies: An Introduction to the Interpretation of
Visual Materials, to devise the methodological strategies. Two approaches are incorporated—―Discourse
Analysis I‖ and ―Discourse Analysis II.‖ Discourse Analysis I focuses on ―discourse as articulated through
various kinds of visual images and verbal texts‖ (Rose, 2002). Using this method will allow me to engage
the visual images and language from both the print and television advertisements for what is actually being
projected from the screen or print, and what is to be understood by the overall images and word choices.
Discourse Analysis II which ―tends to pay more attention to the practices of institutions than it does to the
visual images and verbal texts‖ (Rose, 2002), allows me to analysis Merck and the marketing firms
responsible for creating the commercial campaigns, bringing a depth to the research that dealing with the
images alone cannot do. This process will enable me toeffectively interpret the messages from the

38

commercials side-by-side the ethical and political questions raised about the lobbying initiatives for
vaccination requirements of eleven- and twelve-year-old girls entering middle school. Again, both
methods are infused because this project is as much about the images in the advertisements as the ways in
which Merck & Co.usedtheir power as a multi-national pharmacutical company to control public
understanding of HPV, cervical cancer, and ideal treatment.
The following are the steps taken to conduct the analysis for ―Make the Connection,‖ ―Tell Someone,‖
and ―One Less/ I Choose‖:


Define each campaign and discuss the particular agenda as part of the overall marketing strategy.



Watch two commercials per campaign and observe two print advertisements paying close attention
to the ways that race, class, girl power, and feminist language informed the messages of the
commercials.



For depth and robustness of this project, a set of questions were created to help guide my
observations. The questions also guaranteed that each ad received equal examination. (Refer to
Appendix A)



Wrote a list of all reoccurring images and words for each ad allowing me to effectively and
concisely deconstruct and write my analysis of each print and television advertisement. The written
analysis of each ad is included in the next section of this chapter.

Furthermore, deciding what commercials and print advertisements were used in the research was
accomplished through the internet search engines Google and YouTube. After I found the commercials,
secondly, I observed six different GARDASIL® commercials, three ―Make the Connection‖ commercials,
and two ―Tell Someone‖ commercials for a total of eleven videos. Of the eleven videos, I choose the two
commercials per campaign that had the highest viewing hits. Print advertisements were collected, again,
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through process. I found print marketing of GARDASIL® through Google image searches, magazines, and
flyers located on the campuses of local Atlanta, Georgia, colleges and universities. I gathered a total of 20
print advertisements. After close consideration, I narrowed the print advertisements to six, two for each
marketing campaign. I wanted the number of television and print advertisements for each campaign to be the
same. It was also imperative that the ads used were ones in which images were widely seen and easily
accessible. In other words, if it took minimum effort to search and had several viewed hits on ―YouTube‖
along with being ones that I had actually watched on television or read in a magazine, those became the ones
chosen. I wanted the most popular images from the campaigns to work with in order to connect this research
to what the consumer would have actually watched or read. Therefore using my own memory became
important to my methodological approach. It became necessary to recall the feelings and thoughts I had when
I first noticed the HPV and GARDASIL® commercials on television or in print. My interest was piqued, as I
was, at the time, statistically, among the demographic of young women with whom the issues of HPV and
early detection of cervical cancer are critically important. From my standpoint and memory of the campaigns,
I include my impressions of the advertisements. Additionally, a rigorous feminist research process of
reading, analyzing, and writing focused on how systems of power and privilege are utilized in the marketing
strategies was applied. Therefore the overarching agenda of this project is aligned with a feminist agenda of
gender justice by focusing on how the marketing geared towards women affects women.
Yet there were external threats to be carefully considered throughout the process of this project. The
following were the possible threats: making ―truth claims‖ about the drug, maintaining a new perspective
while continuously viewing the visual images, and only focusing on two forms of marketing—print and
television.What does this mean? The claims about the drug by the manufaturer are important to distinguish
from my point of view of the product. I critiqued the marketing and truth claims in the commercials, while
ensuring my observations of the marketing are distinct from a personal view of the product itself. In other
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words, I do not make a conclusion about the drug's effectiveness. Nor, do I make a recommendation for or
against a girl or young woman getting vaccinated. Finally, I do not endorse or condone the use of
GARDASIL®.A balanced point of view is critical to examining each visual image, according to Gillian Rose,
through ―fresh eyes.‖ The project requires looking at the images several times in order to best apprehend the
meanings of the messages, therefore it is imperative to payclose attention to noting the new aspects of the
advertisments after each observation. In order to accomplish both paying close attention to the images while
looking at them repetitively requires watching each as though it is the first time, hence, allowing me to catch
nuances in the images or important phrases perhaps missed without applying this discipline.
In conclusion, this project focuses on the print and television ads and lobbying strategies as the
primary outreach and marketing strategies for Merck & Co's GARDASIL®. Merck also used websites, text
messaging, and community facilitatorsarmed with Merck's informational toolkitstoadvance their product and
branded message to women. Merckarguablyused a variety of innovative ways of promting their message and
product, that in a larger study would need to be considered. Obviously all of these methods reach consumers
in different ways,possibly impacting their decision making about the drug. These methods, however, are not
included in this study.Therefore this study is limited by virtue of the kind of marketing identified as the focus
of the study.
The next section of this chapter is about the three identified HPV/cervical cancer and GARDASIL®
marketing campaigns. The section is written in chronological order beginning with ―Make the
Connection/Charm4Life,‖―Tell Someone,‖ and ―One Less/ I Choose.‖ Each campaign has its own
subheading with a summary of purpose, description, and analysis of every print and television advertisement.
Close attention was paid to describing the repeating signs and symbols, the representation of women and girls
of color, and highlighting key statements either written in the print ads or spoken by actors in the
commercials. Finally, the corresponding television and print advertisements are added to the Appendices B
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and C and can be referenced while reading this discourse analysis.
4.1

“Make the Connection/ Charm 4 Life”Campaign Synopsis:

Primarily an online public education campaign, ―Make the Connection/Charm 4 Life‖ focused on
creating awareness about the link between HPV and cervical cancer. Financially supported by Merck & Co.,
this campaign collaborated with non-profit advocacy organizations: Step Up Women‘s Network and the
Cancer Research and Prevention Foundation(Siers-Poisson, 2007). The non-profit partnerships enabled
Merck to evade ethical suspicion of a multi-national corporate pharmaceutical entity creating the messaging
for a public health awareness campaign. At the same time, strategically partnering with women founded and
led national advocacy organizations validated Merck‘s outreach to women especially about an intimate
women‘s health issue. ―Make the Connection‖ and ―Charm 4 Life‖ were incentivized campaigns. In the case
of ―Make the Connection,‖ it arguably targeted young women and girls because it offered free beaded braided
bracelet educational kits, symbolizing the HPV/cervical cancer link, through its website. By filling out an
online survey, women and girls would receive in the mail a free bracelet. For every order, two bracelets were
sent upon forwarding Merck‘s message of HPV/cervical cancer link to other woman and Merck would donate
one dollar towards cervical cancer research (Make the Connection Bracelets, 2007).This philanthropic gesture
on the part of Merck demonstrated their commitment to cervical cancer research to the public. At the same
time, Merck was shaping a national narrative about cervical cancer that was mostly interested in emphasizing
its link to HPV.
Even more, the ―Make the Connection‖ campaign enlisted celebrity spokesmodels such as Latina
actress, America Ferrera; African-American actress, Kimberly Elise; and Caucasian actress Elisabeth Rohm.
These women wore the bracelets or other paraphernalia at public events, discussed the campaigns in
interviews or starred in ads. Kimberly Elise and Elisabeth Rohm were featured in separate ―Make the
Connection‖ made for television public service announcements co-created by Parallax Productions, Inc.,
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Merck, Edelman, Step Up Women‘s Network and Cancer Research and Prevention Foundation. The website
of Parallax Productions, Inc. under their ―success stories‖ link, reports the record number of impressions these
PSA‘s received. Impressions are defined as, ―a cable-box stays tuned to a given channel for at least five
seconds during the time when an ad is showing is calculated as viewing the commercial‖ (Google, 2011).
According to Parallax Productions, Inc. ―The first iteration aired from January–October 2006 and starring
Elisabeth Rohm, earned over 83 million impressions…In 2007 still in heavy rotation and now featuring
Kimberly Elise…earning over 85 million impressions.‖ The message of HPV and cancer linkage was
pervasive through these ads and effectively set the stage for GARDASIL®‘s subsequent announcement.
Parrallax Production, Inc. also stated that the ads were broadcast on ―1,000 stations.‖
―Charm 4 Life,‖ similar to ―Make the Connection,‖ was a partnership for Merck with jewelry
company Alex and Ani to spread the message of HPV‘s connection to cervical cancer with a bracelet. In this
instance, according to the website, ―a limited edition ‗Charm 4 Life‘ bangle set…4 expandable bangles: three
plain bangles and the Chinese peony charm bangle.‖ This bracelet retailed at thirty-two dollars with five
dollars of every sale going towards cancer research. ―Charm 4 Life‖ was a limited campaign that targeted a
woman who may want to make her own donation towards cervical cancer research through purchasing a
bracelet. Following the announcement of GARDASIL® this campaign also ended and a less publicized
campaign was created called ―Make the Commitment‖ that ran for a few months in 2007. Again, this was a
public awareness campaign with the same agenda to give bracelets in exchange for information and Merck
would donate towards cervical cancer research(Siers-Poisson, 2007).
(Go to appendix B to view Charm 4 Life Print Advertisements)
―Charm 4 Life‖ Print Advertisement I: The print ad includes two young, attractive, able-bodied
women who appear to be their mid-twenties. They are standing next to each other, leaning shoulder-toshoulder heads tilted towards one another smiling and looking directly at the camera. Their arms are
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folded, showcasing the ―charm 4 life‖ bracelets. One model is Caucasian and the other is a woman of
color. The positioning of the models indicates to the viewer that they are friends as they slightly lean on
each other‘s shoulders. This connection at the shoulders also is symbolic of women leaning on each
other for support. In the context of the commercial the women leaning on each other represent the
action desired by the marketer for women to pass the information of HPV and cervical cancer‘s link to
the women in their lives. The attire worn by the models is vibrant and modest. The ad pays careful
attention to strike a balance of attracting viewers while maintaining a demure appearance from the
models. This a far stretch from typical magazine advertisements that take the opportunity to, at the least,
use sexual suggestion as a way to arouse consumers with scantily clad clothing, evocative facial
expressions, and suggestive poses from models. However, in this instance, Merck attempts to both raise
awareness about the link between HPV and cervical cancer while evading the issue of HPV as a sexually
transmitted infection. Therefore the marketing requires a subtle approach, with fully clothed models
wearing bright color creating a welcoming appearance and youthful appeal. Right below the charm
bracelet of the Caucasian model, reading from left to right, are the words ―Charm 4 Life‖ prominently
placed in white letters. The adjacent message written in a smaller font explains the initiative, ―Alex and
Ani join forces with Merck & Co., Inc. to promote awareness…‖ and to raise funds for cervical cancer
research. It further lets the reader know they can learn more about HPV and cervical cancer by going to
the ―Charm 4 Life‖ website.
―Charm 4 Life‖ Print Advertisement II: The dramatic black and white advertisement creates a
visual trick, as it uses mirrors and reflection to create one continuous hand with the wrists acting as the
bridge between the hands. Several ―Charm 4 Life‖ bracelets adorn the wrist of what appears to be a
Caucasian woman‘s hand with the fingers arched and dipped in water. FiercePharma, an online
pharmaceutical industry newsletter, describes the ―Charm 4 Life‖ campaign as an industry trend called
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―indirect ads.‖ This avant-garde advertisement evokes a piece of art. It is an abstract approach to
demonstrating Merck & Co. message of HPV‘s link to cervical cancer. The vague details included in
this advertisement that would encourage the curious to go to the ―Charm 4 Life‖ website to learn more
about the campaign. ―Merck has been promoting its Charm4Life campaign in women's magazines.
‗Talk to your doctor,‘ the site suggests. ‗Or find out more for yourself right now.‘ The ‗find out more‘ is
hyperlinked to a GARDASIL® website‖(Siers-Poisson, 2007).
―Making the Connection‖ Television PSA I: Featuring Kimberly Elise, the sixty-second PSA is
entitled ―Girlfriends.‖ It is set in a living room with a plush beige couch as the room‘s focal point. The
room utilizes warm colors, open space, and minimalist modern décor, making it appear as an inviting
and comfortable feminine space. The room looks like that of a single professional woman‘s living room
with no visual markers of children or a spouse—such as framed photos. Furthermore, Kimberly‘s
disposition is that of a trusted friend. A woman, that other women could imagine being the kind of nonjudgmental friend they could exchange personal information with. In the commercial Kimberly is
wearing a comfortable and feminine outfit including a pink blouse and light pink make-up. She sits on
the coach while throughout the commercial the camera shows her in various comfortable poses. As the
only person in the ad, Elise speaks directly to the camera maintaining audience interest by speaking in a
light and humorous voice, while at the same time articulating a quite heavy and significant message.
Elise opens by asking women what was the last conversation they had with their girlfriends.
Subsequently, she answers the question by stating options such as talking about clothes, shoes and work.
She then offers an additional conversation women need to have with each other, a conversation about
the connection between HPV and cervical cancer. She then adds that African-American women may be
disproportionately at risk of getting cervical cancer. This statement is made without offering any
rationale as to why African-American women are disproportionately at risk, or how to learn more about
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African-American women‘s risk factors. As a matter of fact, I did not find another Merck sponsored
HPV/cervical cancer PSA that made this claim about African-American women‘s risk factors.
However, Elise as an African-American woman is assigned this task of making this claim. She is able to
make this claim as an African-American woman, about African-American women‘s health, without the
need to substantiate such claim. She does, however, encourage women to learn more about the
connection by going to the ―Make the Connection‖ website. The website address then appears on the
screen below her face along with the logos and names of the non-profit partners of Merck who are
responsible for the public health message. At the end, Elise mentions all the organizational partners
except for Merck, although Merck‘s name appears on the screen with the other
partners(http://www.parallaxproductions.com/videogallery.php).
―Making the Connection‖ Television PSA II: Elisabeth Rohm, former actor of the television
series Law and Order, is the star of the ―Make the Connection‖ thirty-second public service
announcement. Seamlessly, the role she played as a district attorney on Law and Order is the same
persona for the ―Make the Connection‖ public service announcement. The PSA opens with Rohm, in
business attire, sitting on steps outside an office building on a sunny mid-afternoon. Behind her, two
women one Asian and young, and the other Caucasian and mature, both wearing suits are walking out of
the building and down the stairs behind Rohm. In a professional and confident stance, Rohm leans
towards the camera and firmly states that she has information that will ―save your life.‖ She continues
by stating that some types of HPV are linked to cervical cancer. Next, the camera focuses on the Asian
and Caucasian women walking. As they walk, the Asian woman looks at the Caucasian woman and
states with concern, ―it is a cancer diagnosed in thousands of American women every year.‖
The camera then pans on other women who are discussing the same issue with each other, or into
the camera talking directly to the viewing audience. Therefore, the next scene is of a bustling city

46

sidewalk—the camera faces a beautifully landscaped park and an African-American woman jogs on the
sidewalk. As she runs, she looks towards the camera and states, ―…but cervical cancer can be
prevented…‖ A Latina police officer speaks next. While walking, the officer passes a ―Make the
Connection‖ logo sign and continues the line of thought started by the jogger, she says:―…through
recommended pap screening and treatment if detected.‖ A Caucasian mother and daughter are next.
They are walking from the park as though they maybe coming from a lunch date. The mother looks at
the daughter and says, ―Help others make the connection between cervical cancer and human
papillomavirus.‖ Simultaneously the make the connection website appears on the screen. In the last
scene, the camera goes back to Elisabeth Rohm, still sitting on steps outside the office building. She
looks directly at the camera and says, ―To learn more about the connection between cervical cancer and
HPV visit maketheconnection.org.‖ As the camera does a close up of her face, underneath remains the
―Make the Connection‖ website address, and below the website are the names and logos of all the
sponsors (from left to right): Cancer Research and Prevention Foundation, Merck & Co., Inc., Step Up
Women‘s Network.
The advertisement‘s in town setting, during a workday, with women appearing as self-sufficient,
of ―average‖ size, and middle-class create a sense to the viewer of ―regular‖ women who are concerned
with their health and therefore validated to discuss the issue of cervical cancer and HPV‘s connection.
Racial and age diversity were also an important aspects of this public service announcements appeal,
including one Asian woman, four Caucasian women, one African-American woman, and one Latina.
These women look relatable. Class is an interesting factor in this commercial because the idea that
middle class as ―right and moral‖ is suggested. These are the kind of women who can, for the sake of
Merck‘s agenda only discusses HPV in the context of linked to cervical cancer, articulate the message
without evoking ideas of HPV as a sexually transmitted infection. These are the type of women who
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engage in sex and sexual activity responsibly. Otherwise stated, the PSA does not show women at a bus
stop, or working at a fast food restaurant, or cleaning the city sidewalk while talking to other women
about the connection between HPV and cervical cancer. The markers of class used in the commercial
are important as it puts the audience at ease in terms of the kind of women who are to be considered
definitive voices on women‘s health information. Moreover, in Elise‘s PSA ―Girlfriends‖ the health
information was given through a lighter tone almost humorous. In Rohm‘s piece the message was
articulated through a range of voices yet with thoughtful tones.
4.2

“Tell Someone”Campaign Synopsis:

―Tell Someone‖ was the second of the two part unbranded disease awareness campaign that preceeded
the FDA approval of the vaccine GARDASIL®. Like ―Make the Connection,‖―Tell Someone‖ focused on
telling the public about the connection between HPV and cervical cancer. This campaign also included
various paraphenalia such as: postcards, television spots, and an interactive website. However, ―Tell
Someone‖ does not partner with any non-profit organizations. It is soley Merck's national public health
education campaign. Furthermore, the message of ―Tell Someone‖took on a weightier approach to
informing the public of the ―daunting‖ reality of HPV, a ―common‖ virus, being linked to cancer.
Additionally, ―Tell Someone‖ urge women who now know this vital information to share this information
with other women. Merck made sharing this newly found information quite easy as well. They provided
―eight e-cards available at the ‗Tell Someone‘ campaign website‖
(http://www.prwatch.org/node/6208).Also, in the pages of women‘s magazines, eye-catching welldesigned postcards that are easly detachable invitedwomen to send the postcard to other women with
Merck's message ofHPV and cervical cancer linkage. Lastly, Merck and the public relation firms that
created the ―Tell Someone‖ campaign made an impact on the public consciousness understanding of HPV
and its connection to cervical cancer. Due to their marketing innovation they took away a number of
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pharmaceutical insider awards, including the Phame Public Health Award, Best Integrated Campaign, Best
Multicultural Campaign, and Best Unbranded Ad. Merck also took home best Marketer of the
Year(Arnold, 2008).
―Tell Someone‖ Print Advertisement I: The print campaign uses realistic cartoon illustrations of
women in various settings engaged in social activities. In the first ad, two young Caucasian women are in
a hair salon. One woman is doing the other woman‘s hair. Sprouting from the clients hair are the words
―Tell Someone.‖Because the female illustrations are engaged in real life adult women activity, such as
being in a hair salon as a stylist and client, this ensures that the ad does not appear adolescent. Additionally
this ad, like the second print ad examined in this section, are part of an agenda by Merck to have women
pass their message about HPV and cervical cancer on to other women; therefore these ads are designed as
postcards. This particular postcard is charming and artful with whimsical detail making it an aesthetic
delight and something a woman would want to send to a friend. These postcards can be downloaded or
detached from a magazine and subsequently mailed. On the back of the postcard is the message,
―…millions of young women have a virus they do not even know about. It‘s called human papillomavirus
(HPV) and certain types can cause cervical cancer.‖
―Tell Someone‖ Print Advertisement II: African-American women are the subjects of this print
advertisement. Three young adult women sit next to each other wearing salon capes over their clothes
under the hair salon dryers while conversing with each other. Their body posture indicates that they are
friendly with each other. Careful attention was taken with the illustration of each woman. Each woman is a
different hue and has differently textured hair and hairstyles, making them reflect a more accurate
representation of the diversity within the African-American community. Additionally, the clothes,
location, and physical gestures made by the women indicate middle class. These details provide the
necessary texture to have both an attractive and ascertainable advertisement for Merck‘s target audience.
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The ―Tell Someone‖ logo is placed in all caps in between two of the women on the baseboard near their
feet. The picture evokes thoughts of doing activities with girlfriends such as going to a hair salon. The
hair salon theme is engaging because the hair salon, as a women centered space, is often where women
share openly and intimately with each other about their lives. Both print ads were racially specific
postcards suggesting Merck was interested in these ads being in women‘s publications that meet the
interests of different racial and ethnic groups.
Tell Someone Television PSA I: This forty-six second PSA opens at an urban outdoor festival in the
middle of a beautiful day. Lavender ―Tell Someone‖ placards and balloons are displayed throughout. It
looks like a health fair including vendors‘ tents. Actors representing a racially diverse and intergenerational
group of women speak directly to the camera about having just learned about HPV and cervical cancer.
Each woman looks into the camera, and in a testimonial style, express how they feel about just learning this
information. Now that they know about HPV and cervical cancer‘s connection, all of the women articulate
an urgent need to share this information with other women. Each woman states that they want to ―tell a
woman that they love about HPV and cervical cancer.‖The women are wearing business casual attire and
occur to be working professionals and college students. Again, like the previously discussed public service
announcements, the women have the markings of middle-class by virtue of their attire and location of the
advertisement. The racial diversity in the commercial is quite significant with eight African-American
women, seven Caucasian women, two Latinas, and one Asian woman speaking and receiving close-ups to
the camera. As a public health message that is dealing with issues of women‘s sexual health, having
women of color prominently placed in the advertisement is significant as women of color are often
understood in the dominant national narrative as being disproportionately at risk of sexually transmitted
disease. Therefore, the ―Tell Someone‖ disease awareness campaign is qualified due to the use of women
of color. In contrast, the voice of authority was a Caucasian woman wearing medical scrubs and a
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stethoscope and can be assumed to be a physician. She is the voice of reason in the commercial as she
offers viewers advice on how to address their new concern about HPV and cervical cancer.
A departure from the ―Make the Connection‖ PSA, the ―Tell Someone‖ television message uses
overtly fatalistic language to discuss the HPV and cervical cancer‘s link. This time, women with
bewildered faces state, emphatically, that ―cervical cancer is caused by a common virus…‖ This is not even
an abstruse scare tactic, because one woman in the commercial asserts, ―That‘s scary.‖ Additionally, the
women express how profoundly baffled they are to realize that millions of people have HPV. Absolutism
about HPV and its connection to cervical cancer was the tone of this public health/awareness
announcement. However, there was no mention of how women can get HPV and how to prevent the
spread of it. It only focused on convincing women that they need to tell other women that these diseases
are linked. Finally, the PSA asks women to go to hpv.com to find out more information about HPV. I
went to the website and upon entering the site one can read various facts about HPV; notably, at the bottom
of the front page of the website in a small font is the sentence stating, ―Educational content brought to you
by Merck.‖ This is noteworthy because the public service announcement appears to be an independent
message free of any corporate ties. Merck‘s name, logos, or commercial taglines are not overtly a part of
this television PSA—instead the placement of Merck‘s branding is positioned in a subtle manner on a
website that is mentioned to the viewing audience in the PSA.
―Tell Someone‖ Television PSA II: This forty-eight second HPV and cervical cancer awareness
campaign like the others uses a formula of ― everyday‖ or ―normal‖ looking, racially diverse, able-bodied,
and middle class women outside on a sunny day. The backdrop for this commercial was the outside of a
hospital or office building. The women are looking directly at the camera expressing how they feel about
learning that there is a relationship between HPV and cervical cancer. The tone of this commercial is set,
as the opening line is spoken by an olive skin-toned dark haired modestly dressed woman, ―Well it‘s a
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cancer caused by a virus…‖ Immediately following, a young Caucasian woman also discreetly dressed,
states, ―I just found out that cervical cancer is caused by certain types of a common virus, cancer caused by
a virus…‖ With an attitude of disillusionment, she continues by naming the culprit or the virus that is
causing cervical cancer, ―HPV, human papillomavirus…‖This is a pivotal moment for all of the
campaigns, as this is the first time that Merck‘s unbranded disease awareness campaigns are definitively
and overtly claiming that HPV is the cause of cervical cancer. The commercial takes an emotional peak as
an African-American woman speaks next about just learning the news of HPV and cervical cancer. She
pauses and stutters while stating, ―I was stunned at how many people have HPV. I was stunned. Mil—
lions? Millions? That‘s insane.‖ Next, the voice of reason comes in to slightly calm anxiety. Again, the
woman positioned as an authority on the issue is a middle-aged Caucasian woman wearing a white doctor‘s
coat and stethoscope. In this ad she is standing outside of what looks like an entranceway of a hospital.
She firmly yet gently states, ―For most women HPV clears on its own, but for some cervical cancer can
develop. That‘s why it is important for you to talk to your doctor about Pap tests.‖ Her statement is the
only solution in this public health message. Also, her voice is the only partially dissenting voice from the
other more fearful voices, yet is obscured by the majority of voices who are perplexed and nervous about
this information. The following scene is of an African-American mother lovingly and worriedly tapping
the shoulder of her teenage daughter. They do not have a voice, although they look perplexed and the
mother looks off into the distance slightly scared hoping for an answer to this issue. The viewing audience
is left to decide what these women are thinking and feeling, while the voice of the Caucasian woman expert
is completing her statement. Additionally while the mother and daughter stand, both the website and a toll
free telephone number appear at the bottom of the screen, ―tell-someone.com 1-877-now-tell.‖ This
particular scene with the mother and daughter, interestingly, foretells the upcoming ―One Less‖
commercial campaign that will focus on teenage girls and their mothers celebrating having found the
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solution to the crisis of HPV and cervical cancer. The commercial convenes with women declaring to
share this newfound information with other women, especially the women they love. Finally during the
final few seconds of the commercial, the Merck name and logo appeared in the upper right corner of the
screen. This firm and pervasive message colors HPV as the cause of cervical cancer and positions Merck
as the experts on this issue. Again, Merck‘s own research indicated that eighty percent of women did not
know about HPV and its connection to cervical cancer. This was an ideal opportunity for Merck to create
and brand the message about these two diseases in ways that suited their interests. Basically this interest
was monopolizing the public airways with their unbranded disease awareness campaigns rhetoric and
therefore taking creative license about what information or not to say about HPV and cervical cancer.
Bottom line, Merck prepared their audiences with their messaging for the launch of their FDA approved
vaccine, GARDASIL®, and they began this campaign even before the FDA approved the vaccine.
4.3“One Less/ I Choose” Campaign Synopsis:
GARDASIL® was FDA approvedin June of 2006 for girls and young women ages nine to twenty-six.
Subsequently, Merck launched their nationwide savvy color-filled youthful commercial campaigns, ―One
Less‖and ―I Choose‖No expense was spared.―One Less,‖like its predecessors, included an interactive
website, television commercials, and branded paraphanelia.―One Less‖ and ―I Choose‖diverge from the
two previous campaigns,as they are part of Merck's official product promotion campaign.Therefore, the
vaccineGARDASIL® becomes the product that the two previous initiatives were preparing the consumer
to want to purchase. Considered a breakthrough in women's health, it is the first vaccine to guard against
two types of HPV linked to most cervical cancer cases, and two forms of HPV that are linked to other
kinds of HPV disease such as genital warts. In other words, the ―One Less‖ and ―I Choose‖commercials
respond to the previous disease awareness campaigns with the answer to cervical cancer—GARDASIL®.
This sentiment is illustrated by the following quote by Bev Lybrand, Vice President & General Manager,
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HPV Franchise, GARDASIL®, Merck Vaccine Division, ―The full public health benefit of reducing the
burden of cervical cancer and HPV disease may be achieved through broad public awareness and
vaccination with GARDASIL®, which is the driving force behind One Less‖(Unknown, 2006). The
succesful advertisement campaign which was in heavy television rotation during the first few years since
GARDASIL®'s launch showcased a diverse cast of working and middle class girls, young women, and
mothers representing the targeted GARDASIL® consumer base. Through displays of athletisism on the
part of the young women actors,these commercials appear to respect the concepts of bodily autonomy and
choice resulting in a celebratory display of girl power.
―One Less‖ Print Advertisement I: The image of this ―One Less‖ ad is of a teenage white girl
playing soccer outdoors on a sunny day. She is in motion, as the picture shows her giving a powerful
kick to a soccer ball that appears to be hurling off the page. Cleverly, on the front of her soccer jersey is
the number ―1,‖ while the ball she is kicking has the word ―Less‖ written across it with a black sharp
marker. Therefore when reading the soccer jersey and ball, from left to right it states ―One Less.‖
Across the top of the advertisement is the claim by Merck & Co. about GARDASIL®, ―the only cervical
cancer vaccine for girls and young women ages 9 to 26 years.‖ The next sentence of the ad is directed at
parents, ―Your daughter could become 1 less life affected by cervical cancer.‖ This weighted statement
is a cry to parents to make the moral decision to protect their daughters from cancer.
Protection against cervical cancer is Merck‘s claim and focus of the ―One Less‖ commercial
campaign, instead of a focus on the four strains of HPV covered by the vaccine GARDASIL®.
Therefore what the vaccine actually protects against is minimized in the ad, while the claim of
protection against cervical cancer or one possible consequence of an untreated HPV infection is
emphasized. Again, today, less than 0.01% of cancers in the US are cervical cancer. Yet, with FDA
approval and age recommendations, the target market and messaging changed in order to market the
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vaccine. The new messaging focused on cervical cancer prevention for girls and young women ages
nine through twenty-six by getting vaccinated with GARDASIL®. Therefore unlike the previous
campaigns, the One Less commercial uses much younger actors and models side-by-side women
representing mothers, carrying a message of protection for their daughters. The ―Tell Someone‖
campaign message was one of fear, dismay, and disillusionment of discovering that a ―common‖ virus
can cause cancer, along with a directive to tell as many women as possible about this unfortunate fate.
In contrast, the ―One Less‖ ad through the display of athleticism shows self-assured and empowered
girls, young women and mothers because they have access to the tool that protects against cervical
cancer. The women of ―One Less‖ appear to be confident and knowledgeable, while the women of
―Tell Someone‖ are alarmed and seeking answers. Again, GARDASIL® becomes the answer women
are looking for, making the One Less campaign a celebration of girl power contingent upon the use of
the vaccine.
―One Less‖ Print Advertisement II: The ―One Less‖ commercial is of a young woman of color
standing outside during the afternoon in front of a New York City subway station. She is standing next
to the subway entrance sign that states, ―Franklin St. Station Uptown 1‖ while holding a placard above
her head with the word ―LESS‖ boldly written across. She is wearing casual clothing as she holds the
placard smiling and confidently standing for all who pass by to see. She wants the public to know that
she is in control of her life and health by being ―one less‖ young woman of color to get cervical cancer
because she received the GARDASIL® vaccination series.
I examined this print advertisement closely, comparing and contrasting it with the first print ad in
the ―One Less‖ section. Some of the findings from my analysis of both print advertisements, as a black
feminist thinker, are quite compelling. First, the advertisements are similar in the way that the models
are significantly younger than those of the previous campaigns. Also, the young women models are not
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presented to the viewers through a sexualized gaze. Often, in a commercial ad girls are depicted as coy
eye-candy through a heteronormative lens for mass consumption. Instead, the girls in these ads are both
fully clothed with little to no makeup and posed in self-assured ways. These girls are portrayed as
―everyday‖ young women standing in their autonomy and taking control of their health. Yet, race and
even class maybe shaping the design of each ad raising interesting questions about the differences in
them.
For the sake of comparing the ―One Less‖ print ads I will refer to them as ads one and two in this
section. Both ads only show one young woman, however, in ad one, the language indicates that the
soccer player has a family and that GARDASIL® is a family discussion and decision. The ad states,
―Your daughter could be one less life affected by cervical cancer.‖The young white woman is to be
understood as a suburban youth with an after school activity, soccer, and caring parents who always
make the right decisions for their daughter. Advertisement two does not mention family or refer to the
young woman of color as someone‘s ―daughter.‖ She is standing alone in her empowerment outside the
1 train subway entrance going ―uptown.‖ Importantly, the 1 train‘s uptown route includes parts of
Harlem and ends in the Bronx. Therefore, she is a responsible inner city youth, who has set herself apart
from her peers, other inner city young women of color who have not gotten vaccinated. Furthermore,
and with close examination of both ads, each ad does a play on the ―One Less‖ tag line. In ad one, the
young white woman is wearing the number 1 on her jersey. The number ―1‖ has many meanings. ―1‖
can mean being first, or the top of, ahead of, or the winner. The soccer player in the first ad is wearing
the number 1 and therefore is embodying all that it symbolizes. Interestingly, the young woman of color
is holding the latter part of the two words tagline, ―Less.‖ Less, according to the online thesaurus, is
defined as ―smaller or inferior.‖ Some of the synonyms for less include: beneath, declined, deficient,
reduced, and minor. Moreover, while both ads are girl-power inspired, ad one appears more organic or
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realistic with the young woman having purpose by playing soccer. In ad two, the young woman has no
other purpose than holding the ―Less‖ sign above her head in front of the subway train entrance. She is
not being depicted as performing an activity or having any other purpose than holding the sign.
Therefore all the audience knows about the young woman of color is that she has gotten the vaccine
GARDASIL®. Without the placard she would be another (invisible) young woman of color standing on
a city sidewalk in front of a subway station entrance.
―One Less‖ Television Commercial I: The fifty-nine second commercial is a departure from the
previous commercial campaigns in two important ways. First, the prominent faces and voices carrying
Merck‘s message of cervical cancer prevention are much younger. A racially diverse group of teenage
girls engaged in sports or other youthful activities became the center of both the print and television
advertisements. Secondly, both the ―One Less‖ and ―I Choose‖ campaigns are the first time Merck is
presenting a product to the consumer. These two campaigns are the culmination of the unbranded disease
awareness campaigns by presenting the answer to cervical cancer prevention—GARDASIL®.
A Caucasian teenage girl wearing a baseball cap over top her long brown dreadlocked hair, opens the
commercial with a pronounced alto voice stating, ―Each year in the US thousands of women learn they
have cervical cancer. I can be one less.‖ She proudly shows the backside of her skateboard with the words
―One Less‖ written on it. Her attire can be described as alternative or even ―tomboy.‖ Next, she is shown
gliding in the air on her skateboard at a city skateboard park. Soon following, the camera focuses on two
young Latinas wearing red, white, and blue basketball player uniforms while playing basketball on a city
court. Soon after, the camera focuses in on one of the Latina actresses as she chimes in, ―One less statistic.
One less.‖Again, heterogeneity is critical to the commercials formula and, as it progresses, more young
women in various locations are engaged in different activities, also one adult voice, a ―mother,‖ adds to the
discourse on GARDASIL®. Interestingly, the mother diverges, in a sense, from the unifying endorsement
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of GARDASIL® being expressed by the youth. Her warning of the side effects of the drug provides
information to parents watching the commercial by interjecting a voice of reason—an adult voice that
lightly challenges what, up to this point, has been youthful (or naïve) enthusiasm for the drug. As my
analysis has demonstrated, similar to previous commercial series, the voice of reason in these all female
casted campaigns are played by Caucasian middle-aged women. They are positioned as the calming astute
voice able to understand the complexities of the issues. This, arguably, can be contrasted against the
women of color voices in the series that have primarily projected animated emotions whether through fear
of the discovery of HPV and cervical cancer‘s connection, or glee for the vaccine GARDASIL® the
solution to preventing cervical cancer. During my fastidious research of the commercial campaigns, I did
not see women of color actresses playing the role of expert or authority on the issue. That is to say, women
of color are not wearing white medical scrubs and appearing as either doctors or scientists talking to the
consumer about pap smears or GARDASIL® in the advertisements. In the final shots, an AfricanAmerican teenage girl‘s dance troupe is in a dance studio practicing their choreography while snippets of
cheerful girls emphatically state, ―GARDASIL®.‖ The commercial culminates with a different set of
African-American teenage girls playing double-dutch on a city sidewalk chanting the commercial's tagline:
―I will be one less, one less! O-N-E-L-E-S-S, I will be one less!‖ The African American teenagers give the
final endorsement of GARDASIL® with a catchy and easy to repeat tagline that those watching can repeat
long after the commercial is over.
Again, a politically correct commercial from first glance, with a racially diverse group of young
women engaged in sports. However with closer examination, the activities assigned to the diverse group of
youth actors were based largely on specific race and class cultural markers. The result was a commercial
narrative that, again, according to the marketing firm DDB representative, was―filmed in a gritty,
documentary style, the ads intersperse information about GARDASIL®between scenes of teenagers at play
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or hanging out on city streets‖ (Applebaum, 2007). Diverse racial representation is thoughtfully infused in
the ―One Less‖ advertisement; yet, notably, the African-American girls are prominently placed in the
commercial. Their pronounced positioning is demonstrated in a few ways: first, by the numbers of
African-American actresses, secondly, the number of seconds they are viewed in the commercial, and
thirdly, they are the last voices and faces in the commercial chanting the product tagline. They AfricanAmerican actors become the last impression the viewing audience has of GARDASIL® in this commercial.
As the last impression, the African-American actors become a branded face of the product. In other words,
the African-American teenage girl becomes synonymous with the vaccine, and therefore the vaccine in turn
appears to be for African-American teenage girls. Arguably, this racial branding fits easily into a broader
outreach strategy of making the vaccine a public school entrance requirement, which is already the case in
Washington, D.C. Next, sports were a major thread throughout the commercial. Since participation in
sports are regarded as a man‘s domain, the women and girls who enter it are often understood as strong,
empowered and independent, and when demonstrated in a commercial format, this spectacle is a kind of
packagedgirl power or consumption feminism. Moreover, situating the young actors as ―hanging out on
city streets‖ indicates to the viewing audience the economic status of these girls as among the poor and
working class. Therefore in the commercial the actors‘ empowerment is in part due to their choice to be
unlike other ―city‖ girls by taking control of their sexual health by getting vaccinated with GARDASIL®.
―I Choose‖ Television Commercial II: ―I Choose‖ is a sixty-one second commercial that uses a multicultural/multi-racial all female cast. Still shots, simulating a photo booth experience, are used to focus in
on each woman‘s face. From start to finish, the commercial includes attractive young women who embody
individualism discussing their reasons for getting vaccinated with GARDASIL®. The commercial takes
place in each woman‘s unique and contemporary living spaces, while they are doing activities such as
holding a pet, painting, writing or typing on a laptop. These young women appear quite trendy with
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fashionable eyewear, hairstyles, and outfits projecting GARDASIL® as also being in vogue. While the
―One Less‖ commercial targets a pre-teen audience, the ―I Choose‖ commercial caters to the population of
teens and young adult women who are making their own healthcare decisions. This commercial does not
include ―mothers‖ or any other authority figure to explain the side-effects of the drug or ease parents‘
concerns about getting their daughters vaccinated. Instead, these are young adult women talking to young
adult women consumers about the vaccine and urging that it is not too late for them to get vaccinated.
Again, GARDASIL® is a quadrivalent vaccine protecting against four strains of the HPV virus, yet the
―One Less‖ commercial campaign emphasizes only the two strains mostly linked to cervical cancer by
talking about GARDASIL® as a cancer prevention method. In the dominant media narrative about
GARDASIL®, it is known as the ―cervical cancer vaccine.‖However, the ―I Choose‖ commercial allows
the young women actors to talk about both the cervical cancer protection and prevention from other ―HPV
disease.‖ This statement introduces the fact that GARDASIL® protects women from two strains of HPV
that are known to be linked to genital warts. However, the commercial carefully phrases it as, ―other HPV
diseases.‖ I was interested in these word choices because, again, by stating ―other HPV diseases,‖ the
marketing evades the issue of sexual health and sexual contraction of genital warts, perhaps, in part to walk
the fine line of selling the vaccine to both parents and young women. Also, a general statement about the
vaccine benefits may impress upon the viewer that the vaccine may in fact have broad sweeping benefits
other than cervical cancer prevention alone. Again, it is important to reiterate that GARDASIL® covers
four strains of HPV: two strains that are linked to a majority of cervical cancer cases and two strains that
are linked to genital warts, and therefore is not in and of itself a cervical cancer vaccine. The reiteration is
critical to my analysis of the GARDASIL® marketing because the commercials conflate the possible
benefits of the vaccine, while down-playing the actual benefits of HPV prevention.
―I Choose‖ embraces feminist/pro-choice rhetoric to create a woman-centered commercial. As I
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address some of the specific elements in the commercial, I will pay close attention to highlighting the
feminist inspired language used in the commercial. The commercial begins with a young Caucasian
woman sitting on a couch making jewelry while talking about GARDASIL®. She states, ―I choose to get
vaccinated because I will do everything I can to help protect myself from cervical cancer.‖ Following,
another young Caucasian woman who is sitting on a chair petting a small dog, asserts: ―I choose to get
vaccinated when my doctor told me that HPV can affect women my age and how GARDASIL® can
protect me.‖ A young African-American woman speaks next. She is sitting on a couch and softly remarks,
―GARDASIL® is the only cervical cancer vaccine that helps protect against four types of HPV.‖ This
statement highlights the deception in the advertising and raises questions about the truth claims being
made. How can GARDASIL® be called a cervical cancer vaccine? In fact, it would be more appropriate
to call GARDASIL® a vaccine preventing four strains of HPV disease, in which two strains are linked to
the majority of cervical cancer cases. Stated differently, GARDASIL® is an HPV vaccine that may
prevent cervical cancer and not a cervical cancer vaccine that prevents ―four types of HPV.‖ As the
commercial progresses, more young women add to the GARDASIL® testimonials, including two more
quotes that I found of particular interest because they are rich with feminist political language. ―I choose to
get vaccinated, because my dreams don‘t include cervical cancer‖ and ―You have the power to choose.
Ask your doctor about GARDASIL®.‖ Words such as ―chose/choose‖ and ―power‖ in the context of
women‘s health, from women are reminiscent of pro-choice political slogans. These words also symbolize
women‘s empowerment, agency and autonomy of their bodies. The notion of women being able to obtain
bodily agency derives from the movements of women who worked for those rights. It is evident in the
GARDASIL® commercial campaign‘s imagery and language that it is, at the minimum, inspired by
feminist/womanist movement victories and, at the most, a cooptation of feminist language.
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5

FINDINGS AND CONCLUSION

Usually, for-profit companies smartly invest in marketing research to discover the most effective
messaging to convince their target population to buy their medical technologies. Whether the commercial
is promoting an antidote for rheumatoid arthritis, heart disease, or HPV and cervical cancer drug products,
companies use a common formula that resonates with consumers. Routinely these commercials show
conventional looking actors, affirmative drug testimonies, and physical activity in order to sell the
pharmaceutical to a broad consumer base. The use of ―everyday‖ people living fully expressed lives
talking about intimate subjects of disease and treatment with the drug being marketed allows the viewer to
foresee the drug helping their ailments in the same ways projected in the commercials. Merck‘s
HPV/cervical cancer and GARDASIL® commercials use this strategy as well.
I have identified a three-phase marketing campaign bankrolled by Merck & Co. in this research project
focusing on two important women's sexual and reproductive health issues—HPV and cervical cancer. The
first and second phase of the overall marketing strategy began nearly a year prior to
GARDASIL®vaccine‘s offical announcement and FDA approval in June of 2006. Innovative hybrid
public health advertisements regarding HPV and cervical cancer, ―Make the Connection‖ and ―Tell
Someone,‖were designed to ―prime the market‖ or prepare the public for the arrival of GARDASIL®.
These unbranded disease awareness campaigns were underwritten by Merck & Co., and incorporated
public partners to legitimize the campaigns—two women led non-profit organizations—The Cancer
Research and Prevention Foundation and Step Up Women‘s Network, in which, the latter, is also a
women‘s centered organization. Moreover, the ―Bloomberg News‖ reported on the millions of dollars
spent in early 2006, prior to the FDA approval of GARDASIL, as follows: ―in the first quarter this year,
Merck spent 107.3 million dollars on all its advertising, including $841,000 for Internet ads on the human
papillomavirus…Merck also bought 295 TV advertising spot‖(Blum, 2006). The PSAs reinforced Merck's
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message on HPV and cervical cancer with celebrity endorsements, paraphernalia, and significant television
rotation.
Through extensive observation of both the print and television public awareness campaigns, I
ascertained that Merck was promoting a specific message about HPV and cervical cancer, a consistant and
singular message for the public to know and help share: HPV is a widespread virus that can cause cervical
cancer. Moreover, in the unbranded disease awareness commercials, women were made to look stunned,
shocked and bewildered by the news that there is a link between cervical cancer and HPV. In fact, the
―Tell Someone‖series had actresses playing distressed women flustered by learning that a―common virus
causes cancer.‖ As a matter of fact, one actress blurts the word, ―scary!‖ These fear-driven ads did not
provide much resolve for the viewers and instead invited people to go to Merck‘s website to learn more
about HPV and cervical cancer. Merck had positioned itself as the concerned voice of authority on this
vital women‘s health issue. Yet the health education from the Merck funded public service announcements
was limited in scope. They evaded issues of sexual health, including: not explaining what HPV is, or how
this ―common‖ virusis contracted, and, importantly, HPV‘s relationship to genital warts and cervical
cancer. Even more, critical to any public health awareness strategy is information about prevention and
risk reduction. These PSAs do not mention cervical barrier methods or condoms as another tool to lower a
woman‘s chances of infection or transmission of HPV. A yearlong unbranded disease awareness initiative,
―Make the Connection‖ and ―Tell Someone,‖ led up to the FDA approval and announcement of the vaccine
GARDASIL®which purported to provide the resolution to HPV and cervical cancer prevention.
Again, by June of 2006, the FDA approved the vaccine GARDASIL® as safe and effective for women
and girls ages nine through twenty-six. Subsequently, the third phase of the marketing strategy was
launched—―One Less‖ and ―I Choose.‖ These commercial campaigns included an intergenerational and
racially diverse cadre of working and middle class women and girls who spoke confidently about
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GARDASIL®. They spoke of making a ―choice‖ to protect themselves or their daughters from cervical
cancer. A far cry from the disillusioned women of the previous unbranded disease awareness commercials,
these were self-reliant and empowered women and girls who had the answer. There were no celebrities for
this series either, just ―everyday‖ looking female actors as the chief faces and voices endorsing the vaccine.
By using relatable faces and bodies, to the viewing audience, these actors appear to be actual young
women, girls, and moms giving testimony to either getting the vaccine or getting their daughters
vaccinated. The commercial allows the viewer into these women‘s realities with the hopes that the women
and girls watching can find commonality with the actors, and hopefully connect to their projected decision
to get vaccinated with GARDASIL®.
The sixty-second ―One Less‖ commercial discussed in this project is focused on young women. As
the commercial unfolds, the young women look into the camera and state that they will be one less woman
to get cervical cancer because they have been inoculated with GARDASIL®. The young female actors
appear strong, in control of their bodies, and rebelling against the status quo through the displays of
athleticism and individual style. These are empowered young women occupying public spaces that are
often limited to girls, such as an urban basketball court and skate-board park. However, as a form of
consumption feminism, the young women‘s demonstration of liberation is contingent upon their ―choice‖
to be consumers of GARDASIL®.
Using a critical black feminist lens to further examine the affirmative girl power images, the images
became exposed for the ways in which specific race and class stereotypes are utilized and exploited to sell
GARDASIL®. The spectacle of race and class being portrayed in the sixty-second ad is affirmed when
considering the comments by the company who designed the ―One Less‖ campaign, DDB, who used
language associated with urban existence and realities. Therefore a black feminist analysis becomes vital
to unpacking and interrogating both the previous statement and the visual images that make-up the
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campaign. Moreover, the location of the commercial can be understood as showing young women rising
above their environment by making a smart preventative health decision to get vaccinated with
GARDASIL. Now, they will be, as stated by the Latina in the commercial, ―one less statistic‖or young
woman from the ―gritty streets‖ to be exposed to HPVand subsequently die from cervical cancer, the ad
suggests. They are young womenwho are unlike their ―at-risk‖ urban peers who are often considered by
the dominant culture as burdens to the state.
There is seemingly a balance of young white actors to young women of color actors in the ―One Less‖
commercial signifying a racial and cultural recognition on the part of the campaign to market to a broad
audience of American teenage girls. At the same time, the African-American girls as the final voices of the
commercial are chanting the tag-line in a rhythmic easy-to-remember sound allowing the listener torepeat it
after the commercial ends and solidifying them as the face and voice of the product. The GARDASIL®
campaign is successful because it set itself apart from the typical teen marketing campaigns. In part,
because the young women actors are engaged in activities that do not require them to be coy or visually
appealing to the male-centered gaze—which is rare in US media portrayals of teenage girls. Therefore,
thecommercial is a celebration of a newfound freedom for young women allotted to them because of a
GARDASIL® vaccination. These young women are to be understood as ―can-do‖ girls, ideal teenagers,
because they are taking responsibility for their own health. The ―One Less‖ girls become rolemodels that
other girls aspire to be; once vaccinated with GARDASIL®, they no longer have to be ―at-risk‖ girls and
can be ―can-do‖ girls, too.
Publicly, GARDASIL® was being touted as a young-woman friendly, life-saving product receiving
the endorsement of some national feminist health organizations; however, for some women their ability to
choose the vaccine was being stripped through lobbying efforts to mandate the vaccine. Most mandatory
vaccine bills introduced by state legislators failed, yet there were some successes. These
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successesdisproportionately affectedyoung women of color, low-income women, and women seeking
citizenship. The first city to introduce a compulsory inoculation entrance requirement was Washington,
D.C., where seventy-nine percent of the student population is African-American. The D.C. requirement
states that all girls entering the sixth gradehave to be vaccinated with GARDASIL® or provide an opt-out
form signed by parents and given to the schools. Furthermore on July 1, 2008, the Federal Government
through the U.S. Immigration and Citizenship Services or CIS added GARDASIL® as one of its
inoculation requirements for all women and girls (between 11-26 years of age) migrating to or becoming
citizens of this country. As one of the most expensive vaccines on the market, it became an additional cost
burden for women attempting to migrate to this country. A year after it was implemented the requirement
was rescinded mostly due to pressures from immigrant rights groups. Merck has also ensured the vaccine‘s
availability to low-income women through the ―Merck Vaccine Patient Assistance Program.‖The program
can be accessed through the Merck website. According to the website there are minimal requirements
noting that undocumented women are eligible for the program as well. This statement on the website
impressed upon me, in this anti-immigrant climate, that healthcare access especially women‘s access is
used in opportune ways. Therefore, while undocumented women are able to access the vaccine through
this program as a HPV prevention measure, without identification and/ or health insurance that same
woman would experience obstacles to getting an annual cervical screening or Pap smear—an exam that
provides an initial look for cervical abnormalities and the first step towards cervical cancer prevention.
All in all, Merck‘s marketing strategy to distribute the vaccine GARDASIL® has been far-reaching,
targeting women and girls of all races, socio-economic statuses and citizenship statuses. Merck, like its
pharmaceutical company peers, discovered that it is as important to market drugs to patients as it is to
doctors and hospitals. Drug companies are investing ―$5 billion a year selling prescription drugs to
consumers. Direct-to-consumer (DTC) promotion of medications includes advertisements in newspapers
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and magazines, TV ads, coupons, and industry-funded website‖(Pharmed Out and National Women's
Health Network, 2008). Because of advertising, today‘s patients can walk into their doctor‘s office and ask
for a drug by name. The pharmaceutical commercials even suggest this of patients—―ask your doctor
about…‖ With this type of messaging, in essence, consumers are likened to pharmaceutical representatives
acting in the interests of the pharmaceutical companies with their healthcare providers.
As pharmacutical marketing continues to be an ever-present reality with the ―average adult in the U.S.
exposed to 100 minutes of DTC television ads for every minute spent seeing a doctor‖; in response,
consumer advocacy organizations, blogs, and commentary critiquing this phenomenon is also growing and
supporting people becoming astute consumers (Pharmed Out and National Women's Health Network,
2008). It would be disingenuous to conclude this research with the impression that people are at the mercy
of pharmaceutical companies‘ massive budgets to create persuasive marketing campaigns forcing them into
acquiring drugs they otherwise would not use. Or, that there has not been a clear progressive benefit to
consumers learning about new drugs through mainstream media. Medical information that used to be
nearly privileged information accessible only to healthcare providers, today, with a click of a mouse, can be
quickly obtained by almost anyone, and, in some ways, the knowledge has been democratized. Healthcare
advocates, in particular women‘s health advocates, such as the National Women's Health Network,
continue to work diligently for the rights of consumers of medicine to have access to up-to-date rigorously
researched medical information. Therefore, as this research project has focused on the Merck & Co.
strategies to widely distribute their message about HPV/cervical cancer and to sell the vaccine
GARDASIL® to women and girls, I have included in this final chapter the voices of women and girls who
are critiquing the marketing of GARDASIL®. These are young women who are ―resisting‖ the marketing
from the pharmaceutical giant in creative ways.
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5.1

Resisting the Marketing

Not all young women have been impressed by the celebration of girl power through Merck's version of
consumption feminist marketing nor sold on the vaccine. These young women and girls have used
technology to create and disperse skeptical, in some instances, satirical public statements critiquing
Merck‘s HPV/cervical cancer and GARDASIL® advertising campaigns. It was through the many web
searches for information about Merck‘s campaigns that I found these forms of resistant narratives within
my search results. Specifically, the widely used video uploading and sharing website YouTube had several
video shorts critiquing GARDASIL®. These videos featured young women questioning the viability of the
vaccine in their lives and mocking the ―One Less‖ commercial format. To maintain cohesion within the
project, I decided to focus on print and film forms of activism. I have included one commercial parody of
the ―One Less‖ television ad, and one print ad that is similar to a GARDASIL® print advertisement. The
commercial parody is called ―Protectasil,‖ and the print ad is designed similar to the GARDASIL® New
York City subway advertisement featuring a young woman of color.
GARDASIL® Video Parody I: The fifty-eight second GARDASIL® parody entitled ―Protectisil‖
features a young Caucasian adult female sitting outside a school parking lot. It is a sunny day and in the
distance people are walking out of the school building. Similar to the format of Merck‘s HPV/cervical
cancer and GARDASIL® advertisement campaign format, the young woman explains why she has gotten
vaccinated with Protectasil. Satirically speaking she looks into the camera and talks about why she got
vaccinated with Protectasil, as though she is talking to a close friend about getting vaccinated. She states,
―…smart enough to know that when a major pharmaceutical company tells me to take a drug whose long
term effectiveness is unproven, I should just trust them. Why? Because smart girls do what they are told,
and they don‘t ask questions…‖
In the next scene the actress is skipping in the background while the ―Protectasil‖ logo emerges to the
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foreground of the video. The actress returns to the scene, now, like a pesky friend, aggressively insists that
the viewer get vaccinated as well. At this point in the parody she mocks the pharmaceutical company‘s
insistent outreach initiatives by not taking no to the vaccine as an adequate response. As if acting in the
interest of the pharmaceutical company, she also volunteers to take the viewer to get the vaccine. Pursuing
the friend/viewer she assures them that they do not have to be concerned about any circumstances that may
forbid them to get the vaccine, because she, as the pharmaceutical company, has addressed all hindering
issues allowing for the viewer/friend to get the vaccine. While a laugh track plays in the background
ensuring the comedic nature is understood, she says: ―What are you waiting for? Do you need a ride,
because I can drive you, or I‘ll pay for the cab…the drug company reimburses me. Did I mention that you
get free juice and cookies afterwards? What is your address…because I could just come over and inject
you myself.‖ The piece ends with the young woman looking into the camera while the voice of an adult
male carries the final statement. In a patronizing patriarchal bass voice, he states, ―Protectasil, just be a
smart girl and get it.‖ The Protectasil parody addressed several issues that have been part of the public
debate about tactics used by Merck to widely distribute the vaccine such as limited information about HPV
and cervical cancer, and Merck‘s attempts to mandate the drug. The invisible yet prominent male voice at
the end of the parody represented, in many ways, how aspects of women‘s health are regulated by the state
and in essence under patriarchal surveillance. The statement that ―smart girls don‘t ask questions‖ is quite
humorous as well as an oxymoron. The statement pokes direct fun at the consumption of the feminist and
girl power spectacle of the GARDASIL® commercial that insists women have choice about their health
under the guise of using Merck‘s product.
Print Parody Ad I: The parody print advertisement shows a smiling young woman of color in casual
dress standing up inside a crowded subway car. The caption written in white underneath her face and
across the front of the advertisement, from left to right, reads, ―Next Stop…GARDASIL®.‖ At the bottom
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right of the advertisement are the words, ―I don‘t think so!‖ At first look, the ad appears to be an
endorsement of GARDASIL® as it looks very similar to the official GARDASIL® advertisement. Even
more, with the model‘s smiling face upon first glance she looks like she is celebrating and endorsing
GARDASIL® like the young women models and actors do in the actual commercials. Her posturing and
friendly face makes the statement at the bottom of the ad quite pronounced. The rejection of
GARDASIL® is emphasized with the use of red letters and an exclamation point. The final statement in
red letters juxtaposed with the model‘s smiling face, incites both comic relief and reflection to think about
why she is rejecting this drug. The ad is focused on one woman as opposed to two or more women
rejecting the drug, evokes the idea of her as an independent free thinker. Someone who is not impressed by
what the popular view is of the product. Instead she is talking back at the notion that vaccination is ideal
and takes a strong stance against getting GARDASIL®.
Highlighting these two parodies featuring young women is important to the overall success of this
feminist discourse analysis research project. It gives another texture to this project by showing that women
are not passive and naïve victims of Merck & Co.‘s aggressive multi-million dollar marketing scheme.
Instead, the parodies are a window into a perspective that has not been featured in most of the critical
literature written about GARDASIL®. In other words, young women and girls who have dissenting views
about GARDASIL® marketing are able, through this medium, to ―talk back‖ and respond to the dominant
marketing narrative that portrays young women and girls of all backgrounds as united in favor of
GARDASIL®. The protest parodies demonstrate that Merck‘s women-centered marketing for a product, at
the time, that was only for women was not above scrutiny from women. The protesters‘ strategic use of the
Internet, especially ―YouTube,‖ a medium that allows for visually projecting a point of view, was an
effective method to send their messages of resistance to ―Big Pharma‖ and society at large. They are able
to instantly have their perspectives about the vaccine be watched, listened to, and passed along globally.
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These are young women who are skeptical of the supposed women friendly girl-power marketing and use
guerilla style parody protest marketing to express their view.
Again, this segment was important to add because throughout the duration of this research project, I
found minimal work written by or including the perspectives of young women and girls. Yet they are the
demographic that is being targeted by the GARDASIL® lobbying and marketing campaigns. Young
women‘s voices were mostly marginalized from the debate, except through these creative media such as
the YouTube videos and mock print advertisements. The prominent literature is written by
adult/authorities speaking and writing on behalf of girls and young women. These adult/authorities,
feminist scholars included, are debating the viability of the vaccine and its place in the future of women‘s
health. However, feminist scholars and advocates must lead the challenge insisting that feminists and their
peer scholarly researchers and health authorities include young women and girls in the fold as valid and
valued knowledge producers of their own healthcare experiences. Furthermore, young women and girls
need to be included as having solutions worthy of inclusion, not just as having a reaction or response to the
issues that affect them.
Consumption feminism is not new. Merck‘s co-opting of liberal feminist language, women‘s
movement gains, and girl-power images to make profits off of the bodies of girls and women is a part of
continuum of marketing schemes that have done the same successfully. Merck‘s use of language such as
―choice‖ in the context of women‘s health is affixed in the popular imagination to feminism and ―prochoice‖ activism. I assert that feminists must continue to be ever vigilant of these moments, especially the
ways that these sites of power(in this instance Merck & Co.) use their power, and how women are affected
both pro and con. Moreover, I envision a feminist response that would courageously require ―Big Pharma‖
to be accountable to women and girls through ensuring the highest ethical standards of their products
including their outreach/ marketing campaigns.
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This critical research project is situated at the intersection of social justice and public health. I offer
this research as part of a critical feminist dialogue about GARDASIL®. The print and television
advertisements campaigns that were identified and critiqued were: ―Making the Connection/
Charm4Life,‖―Tell Someone,‖ and―One Less/ I Choose‖ campaigns. Prioritizing the use of race, class, girl
power and feminist language in the advertisement campaigns was the key to this critical discourse analysis,
and my contribution to the women's studies literature about GARDASIL. Lastly, as a curious women‘s
health advocate, I anticipated, with cautious optimism, the announcement of and subsequent availability of
this breakthrough in women‘s health— GARDASIL®. We are merely at the beginning of knowing all
there is to know about GARDASIL®, and its ability to protect women long-term from the distress that
comes from an HPV or cervical cancer diagnosis. The answers, in my opinion, are in the questions.
Questions like the following: Cervical cancer is already rare, with routine GARDASIL® vaccinations; will
this cancer become a disease of the past for a new generation of young women? Will young men embrace
the idea of the vaccine as important to their sexual health and get vaccinated? With over forty strains of
sexually transmitted HPV, in which only four strains are covered by GARDASIL®, will we see a
significant decline of overall HPV infections in the US? In other words, do the four strains of HPV that
GARDASIL protects against contribute to a large number of HPV cases, and, therefore with increased
vaccination will we see a sizable decline in HPV disease? Thus far, what is understood by virtue of the
widely spread marketing campaigns are that the claim of cervical cancer protection, in the popular
consciousness, is synonymous with a GARDASIL® vaccination. As GARDASIL® is in its fifth year on
the market, and as more young women, girls, and now young men and boys get vaccinated, time and
diligent research will provide us with the insight on the drug‘s effectiveness.
In reflection, engaging in this research exercise expanded my critical thinking about the ever-shifting
socio-political, economic, global landscape. As an African-American feminist thinker, I am paying close
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attention to the ways that women, especially women of color, are impacting these shifts and are affected by
these shifts. Our collective knowledge or the ability to inform and be informed is becoming easier to
obtain—including medical information. In the U.S., pharmaceutical companies are playing a major role in
shaping the way we get medical/drug information and what information is readily available. Therefore, I
am also concerned with identifying those decision-makers who are creating and shaping public agendas. In
the case of GARDASIL®; Merck & Co. along with legislators, doctors, public health officials, city and
public school administrators, and feminist health advocates are weighing in on the value of mass
GARDASIL® inoculation programs. Discourse on this issue and other controversies surrounding the
vaccine have been a part of the public discourse since its approval. Among the most controversial and
highly discussed was Texas Governor Rick Perry‘s attempt to, through executive order, mandate the
vaccine. This effort was met with great resistance by many in Texas, and, subsequently rejected by the
Texas state legislature. However, his cavalier approach to implementing a state-wide GARDASIL®
vaccination requirement in 2006 was not forgotten when Congresswoman Michele Bachmann challenged
Perry‘s decision during recent Republican presidential primary debates. Bachmann challenged his moral
integrity, and financial relationship with Merck & Co.—bringing GARDASIL® front-and-center of the
current political discourse. ―During the Republican debate, Governor Perry denied Merck's political
influence, stating that he received only $5000. However, Merck donated $28,500 to his gubernatorial
campaign and an additional $377,500 to the Republican Governors Association, for which Perry served
as chairman.1 Furthermore, Merck's lobbyist at the time of the executive order was Governor Perry's
former chief of staff‖(Gostin). Perry‘s decision was an egregious abuse of state power, and was rightly
questioned and exposed at that time. On the other hand, Michele Bachmann‘s fear-based, ill-informed, and
fiery rhetoric linking GARDASIL to mental retardation is equally problematic. In a statement to the
media, Bachman says ―after a recent Republican presidential candidate debate in Tampa, Florida, a crying
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woman approached me and said that her daughter received the HPV vaccine and developed ―mental
retardation‖(Portero, 2011). I am not concerned whether or not a woman came to Bachmann and made the
above statement, as I am about her due diligence to back up her oppositional point-of-view with the
research and latest data on GARDASIL® in order to make thoughtful comments. Bachmann‘s poorly
developed and brash statements, along with Perry‘s abuse of executive power, unfortunately, deflect
attention from those having smart nuanced debates about the efficacy and implementation efforts of the
drug—nuanced conversations that are considering: How much influence should a major pharmaceutical
corporation have on public health policy and drug dissemination? Or, if GARDASIL® becomes a public
school entrance requirement for 6th grade girls nationwide, do the students have the right to be informed
with the most up-to-date, age appropriate, and comprehensive sexual health education to go along with the
mandated sexual health vaccine? In other words, how useful and just is it to vaccinate girls with what
Merck claims to be a cervical cancer vaccine, if girls do not know what and where their cervix is? These
are just a few questions of many more that need to have a place in the current political discourse. Finally,
for those of us privileged to research, write, film, create policies and report on the status of women, we
have to continue to insist that women‘s realities are appreciated in their complexities and from their
perspectives. Therefore, I am most interested in engaging with, and contributing to a feminist discourse
that is forwarding a vision that centers justice and love as the modes of protecting and developing civil and
astute societies able to respond, embrace, and hold accountable this ever-changing world.
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Appendix A
Questions for Analyzing Visual Images
1. How many actors appear, and what are the demographics of the actors in the
television and print advertisements?
2. How many times during a television commercial do actors of color appear?
3. How many times during a television commercial do white actors appear?
4.

What words or phrases are repeated in the commercials?

5. Describe what the actors are doing in each commercial.
6. Describe the set or the location and background of the commercial.
7. How long is each commercial?
8. What symbols are in the commercial and which ones repeat?
9. How does the advertisement make me feel?
10. What themes are emerging throughout each television and print advertisement
campaign?
11. In what ways are race, class, and gender performed in the advertisements?
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Appendix B

“CHARM 4 LIFE” PRINT ADVERTISEMENT 1
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―CHARM 4 LIFE” PRINT ADVERTISEMENT 2
http://www.alexandani.com/store/product_info.php?products_id=150
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“TELL SOMEONE” PRINT ADVERTISEMENT 1
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“TELL SOMEONE” PRINT ADVERTISEMENT 2
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“ONE LESS” PRINT ADVERTISEMENT 1
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“ONE LESS” PRINT ADVERTISEMENT 2
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PROTEST/PARODY PRINT ADERTISEMENT OF GARDASIL® 1
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Appendix C
LINKS TO THE MERCK & CO TELEVISION COMMERCIALS REGARDING
GARDASIL®

Make the Connection

•http://www.parallaxproductions.com/videogallery.php
•http://www.parallaxproductions.com/videogallery.php

Tell Someone

•http://www.youtube.com/watch?v=4yV7SpHOcrw
•http://www.youtube.com/watch?v=JUEGhRn5D8c&feature=related

One Less

•http://www.youtube.com/watch?v=hJ8x3KR75fA
•

Parody/ Protest Commercials

•http://www.youtube.com/watch?v=Tvam_2s0Sq8

